UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
Quarterly Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the quarterly period ended June 30, 2003
Commission file number 1-496
HERCULES INCORPORATED
A Delaware corporation
I.R.S. Employer Identification No. 51-0023450
Hercules Plaza
1313 North Market Street
Wilmington, Delaware 19894-0001
Telephone: 302-594-5000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes: |
X |
No: _ |
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act).
Yes: |
X |
No: _ |
As of June 30, 2003, 110,885,674 shares of registrant's common stock were outstanding.
PART I - FINANCIAL INFORMATION Item 1. Financial Statements Hercules Incorporated
Consolidated Statement of Operations
(Unaudited) |
(Unaudited) |
|||||||
(Dollars in millions, except per share) |
Three Months Ended June 30 , |
Six Months Ended June 30 , |
||||||
2003 |
2002 |
2003 |
2002 |
|||||
Net sales |
$ 472 |
$ 437 |
$ 913 |
$ 839 |
||||
Cost of sales (Note 7) |
295 |
267 |
576 |
510 |
||||
Selling, general and administrative expenses |
91 |
84 |
181 |
172 |
||||
Research and development |
9 |
11 |
19 |
21 |
||||
Intangible asset amortization (Note 5) |
2 |
3 |
4 |
5 |
||||
Other operating expense, net (Note 8) |
2 |
19 |
1 |
24 |
||||
Profit from operations |
73 |
53 |
132 |
107 |
||||
Interest and debt expense |
19 |
25 |
38 |
61 |
||||
Preferred security distributions of subsidiary trusts |
14 |
14 |
29 |
29 |
||||
Other expense, net (Note 9) |
6 |
45 |
10 |
49 |
||||
Income (loss) before income taxes and equity income |
34 |
(31) |
55 |
(32) |
||||
Provision (benefit) for income taxes |
5 |
(9) |
13 |
(7) |
||||
Income (loss) before equity income |
29 |
(22) |
42 |
(25) |
||||
Equity income of affiliated companies, net of tax |
1 |
1 |
1 |
1 |
||||
Net income (loss) from continuing operations before discontinued operations and cumulative effect of changes |
||||||||
in accounting principle |
30 |
(21) |
43 |
(24) |
||||
Net income (loss) on discontinued operations, net of tax (Note 4) |
2 |
10 |
2 |
(199) |
||||
Net income (loss) before cumulative effect of changes in |
||||||||
accounting principle |
32 |
(11) |
45 |
(223) |
||||
Cumulative effect of changes in accounting principle, net of |
||||||||
tax (Notes 5 and 13) |
- |
- |
(28) |
(368) |
||||
Net income (loss) |
$ 32 |
$ (11) |
$ 17 |
$ (591) |
||||
Basic and diluted earnings (loss) per share (Note 6) |
||||||||
Continuing operations |
$ 0.27 |
$ (0.19) |
$ 0.39 |
$ (0.22) |
||||
Discontinued operations |
$ 0.02 |
$ 0.09 |
$ 0.02 |
$ (1.83) |
||||
Cumulative effect of changes in accounting principle |
$ - |
$ - |
$ (0.26) |
$ (3.37) |
||||
Net income (loss) |
$ 0.29 |
$ (0.10) |
$ 0.15 |
$ (5.42) |
||||
Weighted-average number of shares - basic (millions) |
110.5 |
109.0 |
110.0 |
109.0 |
||||
Weighted-average number of shares - diluted (millions) |
110.7 |
109.0 |
110.2 |
109.0 |
CONSOLIDATED BALANCE SHEET
(Dollars in millions) |
(Unaudited) |
||
June 30, |
December 31, |
||
2003 |
2002 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 171 |
$ 209 |
|
Restricted cash (Note 11) |
- |
125 |
|
Accounts and notes receivable (net of allowance for doubtful |
|||
accounts of $10 million and $12 million, respectively) |
397 |
360 |
|
Inventories |
|||
Finished products |
96 |
88 |
|
Materials, supplies, and work in process |
86 |
79 |
|
Deferred income taxes |
47 |
46 |
|
Total current assets |
797 |
907 |
|
Property, plant, and equipment |
2,005 |
1,925 |
|
Accumulated depreciation and amortization |
(1,330) |
(1,262) |
|
Net property, plant, and equipment |
675 |
663 |
|
Intangible assets, net (Note 5) |
193 |
198 |
|
Goodwill, net (Note 5) |
499 |
468 |
|
Deferred income taxes |
17 |
15 |
|
Other assets |
426 |
442 |
|
Total assets |
$ 2,607 |
$ 2,693 |
|
LIABILITIES AND STOCKHOLDERS' DEFICIT |
|||
Current liabilities |
|||
Accounts payable |
$ 172 |
$ 176 |
|
Accrued expenses |
231 |
295 |
|
Short-term debt (Note 11) |
21 |
145 |
|
Total current liabilities |
424 |
616 |
|
Long-term debt (Note 11) |
732 |
738 |
|
Deferred income taxes |
77 |
80 |
|
Postretirement benefits and other liabilities |
764 |
758 |
|
Commitments and contingencies (Note 14) |
- |
- |
|
Company-obligated preferred securities of subsidiary trusts (Note 12) |
625 |
624 |
|
Stockholders' deficit |
|||
Series preferred stock |
- |
- |
|
Common stock (shares issued: 2003 - 159,984,444; |
|||
2002 - 159,984,444) |
83 |
83 |
|
Additional paid-in capital |
641 |
682 |
|
Unearned compensation |
(86) |
(93) |
|
Accumulated other comprehensive losses |
(384) |
(454) |
|
Retained earnings |
1,500 |
1,483 |
|
1,754 |
1,701 |
||
Reacquired stock, at cost (shares: 2003 - 49,098,770; |
|||
2002 - 50,615,487) |
(1,769) |
(1,824) |
|
Total stockholders' deficit |
(15) |
(123) |
|
Total liabilities and stockholders' deficit |
$ 2,607 |
$ 2,693 |
CONSOLIDATED STATEMENTS OF CASH FLOW
(Dollars in millions) |
(Unaudited) |
||
Six Months Ended June 30, |
|||
2003 |
2002 |
||
Net cash used in operating activities of continuing operations |
$ (32) |
$ (303) |
|
Cash Flow from Investing Activities: |
|||
Capital expenditures |
(19) |
(13) |
|
Proceeds of investment and fixed asset disposals |
3 |
1,811 |
|
Decrease in restricted cash |
125 |
- |
|
Other, net |
(4) |
4 |
|
Net cash provided by investing activities of continuing operations |
105 |
1,802 |
|
Cash Flow from Financing Activities: |
|||
Long-term debt proceeds |
- |
250 |
|
Long-term debt repayments |
(133) |
(1,770) |
|
Change in short-term debt |
(1) |
(8) |
|
Common stock issued |
14 |
4 |
|
Net cash used in financing activities of continuing operations |
(120) |
(1,524) |
|
Net cash provided by discontinued operations |
- |
25 |
|
Effect of exchange rate changes on cash |
9 |
(4) |
|
Net decrease in cash and cash equivalents |
(38) |
(4) |
|
Cash and cash equivalents - beginning of period |
209 |
76 |
|
Cash and cash equivalents - end of period |
$ 171 |
$ 72 |
|
Supplemental Disclosures of Cash Flow Information: |
|||
Cash paid during the period for: |
|||
Interest |
$ 34 |
$ 66 |
|
Preferred security distributions of subsidiary trusts |
29 |
29 |
|
Income taxes |
20 |
133 |
|
Non-cash investing and financing activities: |
|||
Incentive and other employee benefit stock plan |
7 |
- |
|
|
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)
(Dollars in millions) |
(Unaudited) |
||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||
2003 |
2002 |
2003 |
2002 |
||||
Net income (loss) |
$ 32 |
$ (11) |
$ 17 |
$ (591) |
|||
Foreign currency translation |
50 |
33 |
70 |
(22) |
|||
Reclassification adjustment for loss |
|||||||
included in net income (loss) |
- |
103 |
- |
103 |
|||
Comprehensive income (loss) |
$ 82 |
$ 125 |
$ 87 |
$ (510) |
|||
|
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
(Unaudited)
Prior to January 1, 2003, the Company accounted for stock-based employee compensation plans under the provisions of APB Opinion No. 25, "Accounting for Stock Issued to Employees," and related Interpretations. Effective January 1, 2003, the Company adopted Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation" ("SFAS 123"), as amended by Statement of Financial Accounting Standards No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure" ("SFAS 148"). SFAS 148 amends SFAS 123 by providing alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation and requiring enhanced disclosure regarding stock-based compensation. The Company has elected to apply the fair value recognition provisions of SFAS 123 on a prospective basis to all employee awards granted, modified or settled after January 1, 2003. Awards under the Company's stock-based compensation plans vest over periods ranging from 1 to 10 years. Therefore, the cost related to stock-based employee compensation included in the determination of net income in 2003 would be less than that which would have been recognized if the fair value based method had been applied to all awards since the original effective date of SFAS 123. The Company did not grant any stock-based compensation pursuant to SFAS 123, as amended by SFAS 148, in the first six months of 2003.
Pursuant to the disclosure requirements of SFAS 123, as amended by SFAS 148, the following table presents the pro forma effect on net income (loss) and earnings (loss) per share assuming the Company had applied the fair value recognition provisions of SFAS 123 to all outstanding and unvested stock-based employee compensation.
(Dollars in millions, except per share) |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||
2003 |
2002 |
2003 |
2002 |
||||||
Net income (loss), as reported |
$ 32 |
$ (11) |
$ 17 |
$ (591) |
|||||
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of tax |
2 |
3 |
4 |
6 |
|||||
Pro forma net income (loss) |
$ 30 |
$ (14) |
$ 13 |
$ (597) |
|||||
Earnings (loss) per share: |
|||||||||
Basic - as reported |
$ 0.29 |
$ (0.10) |
$ 0.15 |
$ (5.42) |
|||||
Basic - pro forma |
$ 0.28 |
$ (0.13) |
$ 0.12 |
$ (5.47) |
|||||
Diluted - as reported |
$ 0.29 |
$ (0.10) |
$ 0.15 |
$ (5.42) |
|||||
Diluted - pro forma |
$ 0.28 |
$ (0.13) |
$ 0.12 |
$ (5.47) |
In January 2003, the Financial Accounting Standards Board ("FASB") issued FASB Interpretation No. 46, "Consolidation of Variable Interest Entities" ("FIN 46"), which is an interpretation of Accounting Research Bulletin No. 51, "Consolidated Financial Statements" ("ARB 51"). FIN 46 addresses the application of ARB 51 to Variable Interest Entities ("VIEs"), and generally would require that assets, liabilities and results of the activity of a VIE be consolidated into the financial statements of the enterprise that is determined to be the primary beneficiary. The provisions of FIN 46 apply on a prospective basis to VIEs created after January 31, 2003 and become effective after June 30, 2003 for VIEs existing prior to January 31, 2003. The Company currently has two joint-venture VIEs that are presently accounted for using the equity method of accounting. These entities serve as strategic global marketers of the Company's bicomponent fibers. The assets and liabilities of these entities are not consolidated with in the Company's financial statements. As of June 30, 2003, the fair value of the assets in these joint ventures was approximately $7 million and the fair values of the associated liabilities and non-controlling interests were approximately $6 million. No assets of the Company serve as collateral for the VIEs and the creditors of the VIEs have no recourse to the general credit of the Company. In addition, the Company has two wholly-owned consolidated subsidiary trusts, Hercules Trust I and Hercules Trust II (jointly, "the Trusts"), which are the issuers of the company-obligated preferred securities (see Note 12). Pursuant to FIN 46, it could be determined that (i) the Trusts are variable interest entities and (ii) the Company is not the primary beneficiary of these Trusts. If such determinations are made, the Company will be required to de-consolidate Hercules Trust I and Hercules Trust II, effective July 1, 2003.
In April 2003, the FASB issued Statement of Financial Accounting Standards No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities" ("SFAS 149"). SFAS 149 incorporates provisions that were clarified by the Derivatives Implementation Group. The provisions of SFAS 149 should be applied prospectively to contracts entered into after June 30, 2003. The Company does not believe this statement will have a material effect on its financial statements.
In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity" ("SFAS 150"). SFAS 150 requires certain financial instruments with both debt and equity characteristics to be classified as debt. The statement requires initial and subsequent valuation of this debt at a present or fair market value and is effective July 1, 2003. Upon adoption of SFAS 150 on July 1, 2003, $625 million of Company-obligated Preferred Securities of Subsidiary Trusts will be reclassified from the mezzanine section of the Consolidated Balance Sheet to the long-term liabilities section of the Consolidated Balance Sheet.
On April 29, 2002, the Company completed the sale of the BetzDearborn Water Treatment Business (the "Water Treatment Business") to GE Specialty Materials, a unit of General Electric Company. The sale price was $1.8 billion in cash, resulting in net after-tax proceeds of approximately $1.7 billion. The Company used the net proceeds to prepay debt under its senior credit facility and ESOP credit facility (see Note 11). Pursuant to Statement of Financial Accounting Standards No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets" ("SFAS 144") as adopted on January 1, 2002, the Water Treatment Business was treated as a discontinued operation as of February 12, 2002 and accordingly, all financial information was restated. The loss from discontinued operations for the six months ended June 30, 2002 includes an after-tax loss on the disposal of the business of $230 million. In the three and six months ended June 30, 2003, the Company recognized $2 million in net income for discontinued operatio ns as a result of resolving issues relating to the divestiture of the Water Treatment Business.
The Paper Process Chemicals Business, representing approximately one-third of the business of BetzDearborn Inc. when it was originally acquired in 1998, was fully integrated into and continues to be reported within the Pulp and Paper Division.
Summarized below are the results of operations of the Water Treatment Business for the three months and six months ended June 30, 2002.
(Dollars in millions) |
Three Months Ended |
Six Months Ended |
|||
June 30, 2002 (1) |
June 30, 2002 (1) |
||||
Net sales |
$ 77 |
$ 269 |
|||
Profit from operations |
16 |
49 |
|||
Income before income taxes |
16 |
51 |
|||
Tax provision |
6 |
20 |
|||
Income from operations |
10 |
31 |
|||
Loss from disposal of business, including a provision |
|||||
for income taxes of $0 and $51 million |
- |
(230) |
|||
Income (loss) from discontinued operations |
$ 10 |
$ (199) |
|||
(1) Results of operations for the respective periods are through April 28, 2002. |
Summarized below is the net cash flow provided by discontinued operations for the six months ended June 30, 2002.
(Dollars in millions) |
Six Months Ended |
|
June 30, 2002 |
||
Net cash provided by operations |
$ 28 |
|
Capital expenditures |
(3) |
|
Net cash flow from discontinued operations |
$ 25 |
|
The major classes of assets and liabilities included in the consolidated balance sheet at the time of disposal were as follows:
(Dollars in millions) |
||||
Assets |
Liabilities |
|||
Accounts receivables, net |
$ 161 |
Accounts payable |
$ 55 |
|
Inventory |
76 |
Accrued expenses |
35 |
|
Fixed assets |
217 |
Other liabilities |
178 |
|
Goodwill and other intangible assets |
1,419 |
$ 268 |
||
Other assets |
19 |
|||
$ 1,892 |
Effective January 1, 2002, Hercules adopted the provisions of Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets" ("SFAS 142"). Hercules identified the following reporting units: BetzDearborn, Pulp and Paper, Aqualon, FiberVisions and Pinova. In connection with Hercules' transitional review, recorded goodwill was determined to be impaired in the BetzDearborn and FiberVisions reporting units. In the first quarter of 2002, Hercules completed its transitional impairment review of the identified reporting units and recognized after-tax impairment losses of $262 million in the BetzDearborn reporting unit and $87 million in the FiberVisions reporting unit as a cumulative effect of a change in accounting principle. In addition, an after-tax impairment loss of $19 million was recognized in the first quarter of 2002 relating to the Company's equity investment in CP Kelco, which had an impairment under SFAS 142. Pursuant to SFAS 142, the Company is required to perform an annu al assessment of its reporting units for impairment. The annual assessment was performed as of November 30, 2002 and indicated no additional impairment to the Company's goodwill was warranted.
Accumulated amortization for goodwill upon adoption of SFAS 142 was $185 million. The following table shows changes in the carrying amount of goodwill by operating segment for the six months ended June 30, 2003.
(Dollars in millions) |
Engineered |
||||||
Performance |
Materials |
||||||
Products |
and Additives |
Total |
|||||
Balance at December 31, 2002 |
$ 383 |
$ 85 |
$ 468 |
||||
Foreign currency translation |
31 |
- |
31 |
||||
Balance at June 30, 2003 |
$ 414 |
$ 85 |
$ 499 |
||||
The following table provides information regarding the Company's other intangible assets with finite lives:
(Dollars in millions) |
Customer |
Trademarks |
Other |
||||||
Relationships |
& Tradenames |
Intangibles |
Total |
||||||
Gross Carrying Amount |
|||||||||
Balance, December 31, 2002 |
$ 89 |
$ 70 |
$ 95 |
$ 254 |
|||||
Balance, June 30, 2003 |
89 |
70 |
94 |
253 |
|||||
Accumulated Amortization |
|||||||||
Balance, December 31, 2002 |
$ 11 |
$ 7 |
$ 38 |
$ 56 |
|||||
Balance, June 30, 2003 |
12 |
8 |
40 |
60 |
|||||
Total amortization expense for each of the three-month periods ended June 30, 2003 and 2002 for other intangible assets was $2 million and $3 million, respectively. Total amortization expense for each of the six month periods ended June 30, 2003 and 2002 for other intangible assets was $4 million and $7 million, respectively, of which $5 million was included in income from continuing operations for the six months ended June 30, 2002. Estimated amortization expense for 2003 and the five succeeding fiscal years is $9 million per year for 2003 and 2004 and $8 million per year from 2005 through 2008.
The following table shows the amounts used in computing earnings (loss) per share and the effect on net income (loss) and the weighted-average number of shares of dilutive potential common stock:
(Dollars in millions, except per share) |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||
2003 |
2002 |
2003 |
2002 |
||||||||||||
(Loss) |
Earnings |
||||||||||||||
Earnings |
(Loss) |
earnings |
Income |
(loss) |
(Loss) |
||||||||||
Income |
per share |
income |
per share |
(loss) |
per share |
(Loss) |
per share |
||||||||
Basic and Diluted: |
|||||||||||||||
Continuing operations |
$ 30 |
$ 0.27 |
$ (21) |
$ (0.19) |
$ 43 |
$ 0.39 |
$ (24) |
$ (0.22) |
|||||||
Discontinued operations |
2 |
0.02 |
10 |
0.09 |
2 |
0.02 |
(199) |
(1.83) |
|||||||
Cumulative effect of changes in accounting principle |
- |
- |
- |
- |
(28) |
(0.26) |
(368) |
(3.37) |
|||||||
Net income (loss) |
$ 32 |
$ 0.29 |
$ (11) |
$ (0.10) |
$ 17 |
$ 0.15 |
$ (591) |
$ (5.42) |
|||||||
Weighted-average number of shares - basic (millions) |
110.5 |
109.0 |
110.0 |
109.0 |
|||||||||||
Weighted-average number of shares - diluted (millions) |
110.7 |
109.0 |
110.2 |
109.0 |
For the three and six months ended June 30, 2003 and 2002, the Company had convertible subordinated debentures which are convertible into approximately 0.2 million shares of common stock. However, the common stock shares into which these debentures are convertible have not been included in the dilutive share calculation for the three and six months ended June 30, 2002 because the impact of their inclusion would be anti-dilutive. The dilutive effect of the convertible debentures was included in the calculation for the three and six months ended June 30, 2003. The impact of after-tax interest expense with respect to convertible debentures on net income (loss) is immaterial to the calculation of earnings (loss) per share.
Cost of sales and selling, general and administrative expenses include depreciation expense related to continuing operations of $17 million and $35 million for the three and six months ended June 30, 2003 and 2002, respectively.
Other operating expense, net, for the three and six months ended June 30, 2003 includes $1 million of income and $1 million of expense, respectively, associated with the comprehensive cost reduction and Work Process Redesign program announced in September 2001 (see Note 10). The Company also recognized expense of $2 million and income of $1 million in the three and six months ended June 30, 2003, respectively, as a result of resolving issues related to prior year transactions. Miscellaneous expenses of $1 million were recognized in both periods.
Other operating expense, net, for the three and six months ended June 30, 2002 includes environmental charges of approximately $4 million and $5 million, respectively, restructuring charges of $6 million and $10 million associated with the comprehensive cost reduction and Work Process Redesign program announced in September 2001 (see Note 10), respectively, $6 million for an asset impairment charge in the Performance Products segment and miscellaneous expenses of $3 million in both periods.
Other expense, net, for the three and six months ended June 30, 2003 includes $1 million and $2 million, respectively, in net charges for asbestos-related costs (see Note 14), bank charges of $1 million and $2 million, respectively, and miscellaneous expenses of $2 million and $5 million, respectively. Interest income of $1 million and $2 million was recognized in the three and six-month period, respectively. Litigation costs of $3 million were recognized in both periods. Litigation costs and asbestos-related costs primarily relate to former operations of the Company.
Other expense, net, for the three and six months ended June 30, 2002 primarily includes a $43 million charge for debt prepayment penalties and the write-off of debt issuance costs associated with the repayment of debt with the proceeds from the sale of the Water Treatment Business (see Notes 4 and 11) and approximately $2 million and $6 million, respectively, for litigation costs of a former operating unit.
The consolidated balance sheet reflects liabilities for employee severance benefits and other exit costs of $8 million and $22 million at June 30, 2003 and December 31, 2002, respectively. During 2001, management authorized and committed to a plan to reduce the workforce as part of the comprehensive cost reduction and Work Process Redesign program. Through December 31, 2002, the Company incurred charges related to this program of $76 million, which includes charges of $68 million for employee termination benefits and $8 million for exit costs related to facility closures. During the six months ended June 30, 2003, the accrual for severance benefits recognized in accordance with Statement of Financial Accounting Standards No. 112, "Employers' Accounting for Postemployment Benefits," increased by approximately $3 million. Under this plan, approximately 1,381 employees have left or will leave the Company, of which approximately 1,276 employees were terminated through June 30, 2003. Approximately 52 employees were terminated during the six months ended June 30, 2003. The employees under the plan that have not been terminated are expected to be terminated by December 31, 2003. The plan includes reductions throughout the Company with the majority of them from support functions.
Cash payments during the three and six months ended June 30, 2003 were $5 million and $15 million, respectively, for severance benefits and other exit costs. Severance benefits paid during the quarter include the continuing benefit streams of previously terminated employees as well as those terminated in the current period. Severance benefits were paid in accordance with the Company's standard severance pay plans, or in accordance with local practices outside the United States.
A reconciliation of activity with respect to the liabilities established for these plans is as follows:
(Dollars in millions) |
|||
June 30, |
December 31, |
||
Balance at beginning of period |
2003 |
2002 |
|
Additional termination benefits and other exit costs |
$ 22 |
$ 43 |
|
Cash payments |
3 |
25 |
|
Reversals against goodwill |
(15) |
(39) |
|
Reversals against earnings |
- |
(3) |
|
Transferred with discontinued operations |
(2) |
(2) |
|
Balance at end of period |
- |
(2) |
|
$ 8 |
$ 22 |
Effective January 1, 2003, the Company adopted Statement of Financial Accounting Standards No. 146, "Accounting for Costs Associated with Exit or Disposal Activities" ("SFAS 146"). SFAS 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs in a Restructuring)." SFAS 146 defines the timing of the recognition of costs associated with exit or disposal activities, the types of costs that may be recognized and the methodology for calculating the fair value of such costs. In the six months ended June 30, 2003, the Company did not recognize any costs associated with exit or disposal activities pursuant to SFAS 146.
A summary of short-term and long-term debt follows:
(Dollars in millions) |
June 30, |
December 31, |
||
2003 |
2002 |
|||
Short-term: |
||||
Banks |
$ - |
$ 1 |
||
Current maturities of long-term debt |
21 |
144 |
||
$ 21 |
$ 145 |
|||
Bank borrowings represent primarily foreign overdraft facilities and short-term lines of credit, which are generally payable on demand with interest at various rates. At June 30, 2003, the Company had $16 million of unused short-term lines of credit that may be drawn as needed.
(Dollars in millions) |
June 30, |
December 31, |
|
2003 |
2002 |
||
Long-term: |
|||
6.60% notes due 2027 |
$ 100 |
$ 100 |
|
6.625% notes due 2003 |
- |
125 |
|
11.125% senior notes due 2007 |
400 |
400 |
|
8% convertible subordinated debentures due 2010 |
3 |
3 |
|
Term notes at various rates from 4.07% to 8.56% due in |
|||
varying amounts through 2006 |
48 |
50 |
|
Term B loan due 2007 |
199 |
200 |
|
Other |
3 |
4 |
|
753 |
882 |
||
Current maturities of long-term debt |
(21) |
(144) |
|
Net long-term debt |
$ 732 |
$ 738 |
On December 20, 2002, the Company completed the refinancing of its existing senior credit facility with a new senior credit facility. The new senior credit facility consists of a four year $125 million revolving credit agreement and a $200 million term B loan due May 2007. In addition, the Company has the option of borrowing an additional $50 million to $150 million on terms identical to the term B loan. The incremental term loan will remain available until the earlier of December 20, 2005 or the repayment of the $200 million term B loan. In conjunction with the execution of the credit agreement, $125 million of the proceeds of the term B loan was placed into an escrow account to pay the principal amount of the 6.625% notes in June 2003 and were recognized as restricted cash on the Consolidated Balance Sheet. The 6.625% notes were paid in June 2003 with the proceeds held in the escrow account. The term B loan bears interest at LIBOR + 3.25%. The revolving credit agreement bears interest at LI BOR plus an applicable margin, currently 2.75%, which is determinable based on the Company's leverage ratio. Interest rates are reset for one, two, three or six month periods at the Company's option.
The new senior credit facility is secured by liens on the Company's assets (including real, personal and intellectual properties) and is guaranteed by substantially all of the Company's current and future wholly-owned domestic subsidiaries.
As of June 30, 2003, $55 million of the $125 million revolver was available for use. The Company had outstanding letters of credit associated with the credit facility of $70 million at June 30, 2003.
The Company's new senior credit facility requires quarterly compliance with certain financial covenants, including a debt/EBITDA ratio ("leverage ratio") and an interest coverage ratio and establishes limitations on the permitted amount of annual capital expenditures.
Company-obligated Preferred Securities of Subsidiary Trusts consists of:
(Dollars in millions) |
June 30, |
December 31, |
|
2003 |
2002 |
||
9.42% Trust Originated Preferred Securities (TOPRS) |
$ 363 |
$ 363 |
|
6 1/2% CRESTS Units (CRESTS) |
262 |
261 |
|
$ 625 |
$ 624 |
In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity" ("SFAS 150"). SFAS 150 requires certain financial instruments with both debt and equity characteristics to be classified as debt. The statement requires initial and subsequent valuation of this debt at a present or fair market value and is effective July 1, 2003.
The TOPRS have a scheduled maturity and redemption date of March 31, 2029; the CRESTS have a scheduled maturity and redemption date of June 30, 2029. In accordance with SFAS 150, the TOPRS and CRESTS constitute mandatorily redeemable financial instruments. Upon adoption of SFAS 150 on July 1, 2003, the Company-obligated Preferred Securities of Subsidiary Trusts will be reclassified from the mezzanine section of the Consolidated Balance Sheet to the long-term liabilities section of the Consolidated Balance Sheet.
Effective January 1, 2003, the Company adopted Statement of Financial Accounting Standards No. 143, "Accounting for Asset Retirement Obligations" ("SFAS 143"). SFAS 143, which was issued in June 2001, establishes accounting and reporting standards for the recognition and measurement of legal obligations associated with the retirement of tangible long-lived assets. SFAS 143 requires that the fair value of an asset retirement obligation be recorded when incurred. Included within the scope of SFAS 143 are environmental remediation liabilities that resulted from the normal operation of a long-lived asset. The Company has a number of environmental remediation liabilities associated with current and former operations that were incurred during the course of normal operations. The most significant differences in the measurement of these obligations under SFAS 143 are outlined below:
Recording of Full Obligation: SFAS 143 requires that the fair value of an asset retirement obligation be recorded when it is incurred if a reasonable estimate of fair value can be made. Under SFAS 143, uncertainties (probability) in the amount and timing of settlement are incorporated into the fair value measure of the recognized liability, whereas under Statement of Financial Accounting Standards No. 5, "Accounting for Contingencies," and FASB Interpretation 14, "Reasonable Estimation of the Amount of a Loss," uncertainties are considered in determining recognition of a liability.
Present Value of Obligation: SFAS 143 requires that the fair value of the asset retirement obligation be discounted using a credit adjusted risk-free rate.
Capitalization of Costs Related to Environmental Contamination: SFAS 143 requires capitalization of costs as a component of fixed assets to the extent there is a corresponding operating asset. EITF 90-8, "Capitalization of Costs to Treat Environmental Contamination," permitted capitalization of environmental remediation costs incurred in preparing a property for sale.
With the adoption of SFAS 143, the Company recorded an increase to its environmental remediation liabilities of $28 million with a corresponding increase to property, plant, and equipment of $2 million and a decrease in capitalized environmental remediation costs of $18 million, resulting in an after-tax charge of $28 million ($44 million on a pre-tax basis), or $0.26 per share, as a cumulative effect of a change in accounting principle.
The following table provides a reconciliation of the changes in the asset retirement obligations during the period.
SFAS 143 Adoption |
||||||||||||
Balance |
Cumulative |
Capitalized |
Liabilities |
Balance |
||||||||
January 1, |
Effect |
Retirement |
(Incurred) |
June 30, |
||||||||
2003 |
Adjustment |
Obligations |
Settled |
Accretion |
2003 |
|||||||
Capitalized remediation costs |
$ 18 |
$ (18) |
$ - |
$ - |
$ - |
$ - |
||||||
Environmental Remediation Liabilities: |
||||||||||||
SFAS 143 ARO sites |
(85) |
(26) |
(2) |
8 |
(1) |
(106) |
||||||
Non-SFAS 143 sites |
(3) |
- |
- |
(1) |
- |
(4) |
||||||
$ (70) |
$ (44) |
$ (2) |
$ 7 |
$ (1) |
$ (110) |
|||||||
Guarantees
In November 2002, the FASB issued FASB Interpretation No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others" ("FIN 45"). The initial recognition and measurement provisions of FIN 45 were applicable on a prospective basis to guarantees issued or modified after December 31, 2002. The Company applied the initial recognition and measurement provisions on a prospective basis effective January 1, 2003. FIN 45 modifies existing disclosure requirements for most guarantees and requires that at the time a company issues a guarantee, the company must recognize an initial liability for the fair value of the obligation it assumes under that guarantee. The Company adopted the disclosure requirements of FIN 45 as of December 31, 2002. Disclosure about each group of similar guarantees is provided below:
Indemnifications
In connection with the sale of Company assets and businesses, the Company has indemnified respective buyers against certain liabilities that may arise in connection with the sale transactions and business activities prior to the ultimate closing of the sale. The terms of these indemnifications typically pertain to environmental, tax, employee and/or product related matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the Company would be required to protect, defend, and/or indemnify the buyer. These indemnifications are generally subject to threshold amounts, specified claim periods and/or other restrictions. The carrying amount recorded for all indemnifications as of June 30, 2003 was $90 million.
In addition, in connection with these transactions, the Company has generally provided indemnifications on general corporate matters such as ownership of the relevant assets, the power and corporate authority to enter into transactions and the satisfaction of liabilities not assumed by the buyer. These indemnifications generally have indefinite terms.
Although it is reasonably possible that future payments may exceed amounts accrued, due to the nature of indemnified items, it is not possible to make a reasonable estimate of the maximum potential loss or range of loss. Generally, there are no specific recourse provisions. Approximately $1 million in cash is held in escrow or collateral to cover certain indemnifications related to the sale of a business in 2001.
In addition, the Company provides certain indemnifications in the ordinary course of business such as product, patent and performance warranties in connection with the manufacture, distribution and sale of its products and services. Due to the nature of these indemnities, it is not possible to make a reasonable estimate of the maximum potential loss or range of loss.
Debt Obligations
The Company has directly guaranteed various debt obligations under agreements with third parties related to subsidiaries and affiliates, and/or other unaffiliated companies. At June 30, 2003, the Company had directly guaranteed $23 million of such obligations. This represents the maximum principal amount of potential future payments that the Company could be required to make under the guarantees. Any applicable interest and expenses would generally be added to the amount of the obligations.
Directly guaranteed obligations include approximately $9 million of outstanding obligations which are recorded as debt in the Company's Consolidated Financial Statements. Existing guarantees for subsidiaries and affiliates arose from liquidity needs in normal operations. The Company will be required to perform on these guarantees in the event of default by the guaranteed party.
Intercompany Guarantees
The Company and its subsidiaries have intercompany guarantees between and among themselves which aggregate approximately $145 million as of June 30, 2003. These guarantees relate to intercompany loans used to facilitate normal business operations. All of the $145 million has been eliminated from the Company's Consolidated Financial Statements.
Environmental
In the ordinary course of its business, the Company is subject to numerous environmental laws and regulations covering compliance matters or imposing liability for the costs of, and damages resulting from, cleaning up sites, past spills, disposals and other releases of hazardous substances. Changes in these laws and regulations may have a material adverse effect on the Company's financial position and results of operations. Any failure by the Company to adequately comply with such laws and regulations could subject the Company to significant future liabilities.
Hercules has been identified as a potentially responsible party ("PRP") by U.S. federal and state authorities, or by private parties seeking contribution, for the cost of environmental investigation and/or cleanup at numerous sites. The range of the reasonably possible share of costs for the investigation and cleanup of current and former operating sites, and other locations where the Company may have a known liability is between $110 million and $220 million. The actual costs will depend upon numerous factors, including the number of parties found responsible at each environmental site and their ability to pay; the actual methods of remediation required or agreed to; outcomes of negotiations with regulatory authorities; outcomes of litigation; changes in environmental laws and regulations; technological developments; and the years and timing of remedial activity required, which could range from 0 to 30.
Hercules becomes aware of sites in which it may be named a PRP in investigatory and/or remedial activities through correspondence from the U.S. Environmental Protection Agency ("EPA") or other government agencies or from previously named PRPs, who either request information or notify the Company of its potential liability. The Company has established procedures for identifying environmental issues at its plant sites. In addition to environmental audit programs, the Company has environmental coordinators who are familiar with environmental laws and regulations and act as a resource for identifying environmental issues.
United States, et al. v. Vertac Corporation, et al., USDC No. LR-C-80-109 and LR-C-80-110 (E.D. Ark.)
This case, a cost-recovery action based upon the Comprehensive Environmental Response, Compensation and Liability Act ("CERCLA", or the Superfund statute), as well as other statutes, has been pending since 1980, and involves liability for costs expended and to be expended in connection with the investigation and remediation of the Vertac Chemical Company ("Vertac") site in Jacksonville, Arkansas. Hercules owned and operated the site from December 1961 until 1971. The site was used for the manufacture of certain herbicides and, at the order of the United States, Agent Orange. In 1971, the site was leased to Vertac's predecessor. In 1976, Hercules sold the site to Vertac. The site was abandoned by Vertac in 1987, and Vertac was subsequently placed into receivership. Both prior to and following the abandonment of the site, the EPA and the Arkansas Department of Pollution Control and Ecology ("ADPC&E") were involved in the investigation and remediation of contamination at and around the site. Pursuant to several orders issued pursuant to CERCLA, Hercules actively participated in many of these activities. The cleanup is essentially complete, except for certain on-going maintenance and monitoring activities. This litigation primarily concerns the responsibility and allocation of liability for the costs incurred in connection with these activities.
Although the case initially involved many parties, as a result of various United States District Court rulings and decisions, as well as a trial, Hercules and Uniroyal were held jointly and severally liable for the approximately $100 million in costs allegedly incurred by the EPA, as well as costs to be incurred in the future. That decision was made final by the District Court on September 13, 1999. Both Hercules and Uniroyal timely appealed that judgment to the United States Court of Appeals for the Eighth Circuit.
On February 8, 2000, the District Court issued a final judgment on the allocation between Hercules and Uniroyal finding Uniroyal liable for 2.6 percent and Hercules liable for 97.4 percent of the costs at issue. Hercules timely appealed that judgment. Oral argument on both appeals was held before the Eighth Circuit on June 12, 2000. On April 10, 2001, the United States Court of Appeals for the Eighth Circuit issued an opinion in the consolidated appeals described above. In that opinion, the Appeals Court reversed the District Court's decision which had held Hercules jointly and severally liable for costs incurred and to be incurred at the Jacksonville site, and remanded the case back to the District Court for several determinations, including a determination of whether the harms at the site giving rise to the government's claims were divisible. The Appeals Court also vacated the District Court's allocation decision holding Hercules liable for 97.4 percent of the costs at issue, ordering that these issues be revisited following further proceedings with respect to divisibility. Finally, the Appeals Court affirmed the judgment of liability against Uniroyal.
The trial on remand commenced on October 8, 2001, continued through October 19, 2001, resumed on December 11, 2001 and concluded on December 14, 2001. At the trial, the Company presented both facts and law to the District Court in support of its belief that the Company should not be liable under CERCLA for some or all of the costs incurred by the government in connection with the site because those harms are divisible. The District Court has not yet rendered its decision. Should the Company prevail on remand, any liability to the government will be either eliminated or reduced from the prior judgment.
The Allegany Ballistics Laboratory ("ABL") is a government-owned facility which was operated by Hercules from 1945 to 1995 under contract with the United States Department of the Navy. The Navy has notified Hercules that it would like to negotiate with Hercules with respect to certain environmental liabilities which, the Navy alleges, are attributable to Hercules' past operations at ABL. The Navy alleges that, pursuant to CERCLA, it has spent a total of $24.8 million and expects to spend an additional $60 million over the next 10 years. The Company is currently investigating the Navy's allegations, including the basis of the Navy's claims, and whether the contracts with the government pursuant to which the Company operated ABL may insulate the Company from some or all of the amounts sought. At this time, however, the Company cannot reasonably estimate its liability, if any, with respect to ABL and, accordingly, has not included this site in the range of its environmental liabilities reported above.
At June 30, 2003, the accrued liability for environmental remediation was $110 million. The extent of liability is evaluated quarterly based on currently available information, including the progress of remedial investigations at each site and the current status of negotiations with regulatory authorities regarding the method and extent of apportionment of costs among other PRPs. While it is not feasible to predict the outcome of all pending suits and claims, the ultimate resolution of these environmental matters could have a material effect upon the results of operations and the financial position of Hercules, and the resolution of any of these matters during a specific period could have a material effect on the quarterly or annual results of that period.
Litigation
The Company is a defendant in numerous asbestos-related personal injury lawsuits and claims which typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of the Company's former subsidiaries to a limited industrial market ("products claims"). The Company is also a defendant in lawsuits alleging exposure to asbestos at facilities formerly or presently owned or operated by the Company ("premises claims"). Claims are received and settled or otherwise resolved on an on-going basis. In late December 1999, the Company entered into a settlement agreement to resolve the majority of the claims then pending. In connection with that settlement, the Company also entered into an agreement with several of the insurance carriers which sold that former subsidiary primary and first level excess insurance policies. Under the terms of that agreement, the majority of the amounts paid to resolve those products claims were insured, subject to the limits of the insurance coverage provided by those policies. The terms of both settlement agreements are confidential.
Since entering into those agreements, the Company has continued to receive and settle or otherwise resolve claims on an on-going basis. Between January 1, 2002 and December 31, 2002, the Company received approximately 11,000 new claims, approximately half of which were included in "consolidated" complaints naming anywhere from one hundred to thousands of plaintiffs and a large number of defendants, but providing little information connecting any specific plaintiff's alleged injuries to any specific defendant's products or premises. It is the Company's belief that a significant majority of these "consolidated" claims will be dismissed for no payment. During that same time period, the Company also received approximately 13,000 other new claims, most of which were included in "consolidated" complaints, which have either been dismissed without payment or are in the process of being dismissed without payment, but with plaintiffs retaining the right to re-file should they be able to establish exposure to an asb estos-containing product for which the Company bears liability. Between January 1, 2003 and May 31, 2003, the Company received approximately 12,515 new claims, of which approximately 10,860 claims were included in "consolidated" complaints. The Company is continuing to evaluate whether the claims experience of 2002 and the first five months of 2003, which represents a significant increase over prior years, is an anomaly or a new trend.
With respect to total claims pending, as of May 31, 2003, there were approximately 27,650 unresolved claims, of which approximately 860 were premises claims. There were also approximately 2,030 unpaid claims which have been settled or are subject to the terms of a settlement agreement. In addition, as of May 31, 2003, there were approximately 13,500 claims (including the 13,000 claims noted in the above paragraph) which have been dismissed without payment or are in the process of being dismissed without payment.
In June and July 2003, the Company entered into several settlement agreements which will permanently resolve approximately 12,500 claims. Of those claims, approximately 3,600 are categorized as "unresolved" in the above paragraph, and approximately 8,900 are among those claims that have been dismissed without payment or are in the process of being dismissed without payment. The terms of these settlement agreements are confidential. The Company believes that the vast majority of these claims will be permanently dismissed without payment.
The Company has been advised that the primary and first level excess insurance policies referenced above have largely exhausted, with only minimal limits remaining. The Company has not yet reached agreement with its other insurance carriers to fund the cost of defending and resolving these matters. As a result, until the Company's other insurance carriers begin to fund the cost of defending and resolving these matters, the Company will have to fully fund the cost of defending and settling these matters. Nonetheless, based on the current number of claims pending, the amounts the Company anticipates paying to resolve those claims which are not dismissed or otherwise resolved without payment, and anticipated future claims, the Company believes that it and its former subsidiary together have sufficient additional insurance to cover the majority of its current and estimated future asbestos-related liabilities, as discussed in the paragraph below.
The foregoing is based on the Company's assumption that the number of future claims filed per year and claim resolution payments will vary considerably from year-to-year and by plaintiff, disease, venue, and other circumstances, but will, when taken as a whole, remain relatively consistent with the Company's experience to date and will decline as the population of potential future claimants expires due to non-asbestos-related causes. It is also based on the preliminary results of the study discussed below, the Company's evaluation of potentially available insurance coverage and its review of the relevant case law. However, the Company recognizes that the number of future claims filed per year and claim resolution payments could greatly exceed those reflected by its past experience and contemplated by the study referenced below, that the Company's belief of the range of its reasonably possible financial exposure could change as the study referenced below continues, that its evaluation of potentially availa ble insurance coverage may change depending upon numerous variables including risks inherent in litigation and the risk that one or more insurance carriers may refuse or be unable to meet its obligations to the Company, and that conclusions resulting from its review of relevant case law may be impacted by future court decisions or changes in the law.
The Company is seeking defense and indemnity payments or an agreement to pay from those carriers responsible for excess coverage whose levels of coverage have been or will soon be reached. Although those excess carriers have not yet agreed to defend or indemnify it, the Company believes that it is likely that they will ultimately agree to do so, and that the majority of its estimated future asbestos-related costs will ultimately be paid or reimbursed by those carriers. However, since the Company has not yet reached satisfactory agreements with those excess carriers, the Company will be required to completely fund these matters while it seeks reimbursement from those carriers. In order to maximize the likelihood of obtaining insurance payments for these liabilities, on November 27, 2002, the Company initiated litigation against its excess insurance carriers in a matter captioned Hercules Incorporated v. OneBeacon, et al., Civil Action No. 02C-11-237 (SCD), Superior Court of Delaware, New Castle Coun ty. That litigation is proceeding through discovery and motion practice, and trial is currently scheduled in October 2004. Notwithstanding the filing of this litigation, the Company is continuing settlement discussions with several of its key insurers.
The Company has commissioned a study of its asbestos-related liabilities. That study, which is in progress and expected to conclude later this year, is being conducted by Professor Eric Stallard, who is a Research Professor of Demographic Studies at a major national university and a Member of the American Academy of Actuaries. Professor Stallard is a consultant with broad experience in estimating such liabilities. Based on the initial findings of that study, the Company estimated that its reasonably possible financial exposure for these matters ranged from $200 million to $500 million. Due to inherent uncertainties in estimating the timing and amounts of future payments, this range does not include the effects of inflation and has not been discounted for the time value of money. In addition, the range of financial exposures set forth above does not include estimates for future legal costs. It is the Company's policy to expense these costs as incurred. As stated above, the Company presently believes that t he majority of this range of financial exposures will ultimately be funded by insurance proceeds. Cash payments related to this exposure are expected to be made over an extended number of years and actual payments, when made, could be for amounts in excess of the range due to potential future changes in estimates as well as the effects of inflation.
Due to the dynamic nature of asbestos litigation and the present uncertainty concerning the participation of its excess insurance carriers, the Company's estimates are inherently uncertain, and these matters may present significantly greater financial exposures than presently anticipated. In addition, the asbestos study referenced in the above paragraph is continuing, and further analysis combined with new data received in the future could result in a material modification of the range of reasonably possible financial exposure set forth above. As a result of all of the foregoing, the Company's liability with respect to asbestos-related matters could exceed present estimates and may require a material change in the accrued liability for these matters within the next twelve months. If the Company's liability does exceed amounts recorded in the balance sheet, the Company presently believes that the majority of any additional liability it may reasonably anticipate will be paid or reimbursed by its insurance c arriers. However, there can be no assurance that such liabilities will be reimbursed.
The initial findings of the study referenced above identify a range of the Company's reasonably possible financial exposure for these matters. The Company is not presently able to specify its best estimate of its liability within that range. The Company recorded a gross accrual of $225 million for present and future potential asbestos claims before anticipated insurance recoveries resulting in a net charge of $65 million related to these matters in the period ended September 30, 2002. At June 30, 2003, the Company has a remaining accrual of $199 million for the gross liability. The Company believes that it is probable that $122 million of the $199 million accrual will be funded by or recovered from insurance carriers. At June 30, 2003, the consolidated balance sheet reflects a current insurance receivable of $7 million and a long-term insurance receivable of $115 million. The Company, in conjunction with outside advisors, will continue to study its asbestos-related exposures, insurance recovery expectatio ns, and reserves on an on-going basis, and make adjustments as appropriate.
In June 1998, Hercules and David T. Smith Jr., a former Hercules employee and plant manager at the Brunswick plant, along with Georgia-Pacific Corporation and AlliedSignal Inc., were sued in Georgia State Court by 423 plaintiffs for alleged personal injuries and property damage. This litigation is captioned Coley, et al. v. Hercules Incorporated, et al., No. 98 VSO 140933 B (Fulton County, Georgia). Plaintiffs allege they were damaged by the discharge of hazardous waste from the companies' plants. On February 11, 2000, the Georgia State Court dismissed Georgia-Pacific Corporation and AlliedSignal Inc., without prejudice. In September 2000, David T. Smith Jr., was dismissed by the Georgia State Court with prejudice. On July 18, 2000, the Company was served with a complaint in a case captioned Erica Nicole Sullivan, et al. v. Hercules Incorporated and David T. Smith, Jr., Civil Action File No. 00-1-05463-99 (Cobb County, Georgia). Based on the allegations contained in the complaint, this matte r is very similar to the Coley litigation, and is brought on behalf of approximately 700 plaintiffs for alleged personal injury and property damage arising from the discharge of hazardous waste from Hercules' plant. The Company has settled the claims of all but eleven of these plaintiffs for an amount which is confidential, but which is not material to the financial condition of the Company.
In August 1999, the Company was sued in an action styled as Cape Composites, Inc. v. Mitsubishi Rayon Co., Ltd., Case No. 99-08260 (U.S. District Court, Central District of California), one of a series of similar purported class action lawsuits brought on behalf of purchasers (excluding government purchasers) of carbon fiber and carbon prepreg in the United States from the named defendants from January 1, 1993 through January 31, 1999. The lawsuits were brought following published reports of a Los Angeles federal grand jury investigation of the carbon fiber and carbon prepreg industries. In these lawsuits, plaintiffs allege violations of Section 1 of the Sherman Antitrust Act for alleged price fixing. In September 1999, these lawsuits were consolidated by the Court into a case captioned Thomas & Thomas Rodmakers v. Newport Adhesives and Composites, Case No. CV-99-07796-GHK (CTx) (U.S. District Court, Central District of California), with all related cases ordered dismissed. This lawsuit is proceeding through discovery and motion practice. On May 2, 2002, the Court granted plaintiffs' Motion to Certify Class. The Company is named in connection with its former Composites Products Division, which was sold to Hexcel Corporation in 1996, and has denied liability and will vigorously defend this action.
Since September 2001, Hercules, along with the other defendants in the Thomas & Thomas Rodmakers action referred to above, has been sued in nine California state court purported class actions brought on behalf of indirect purchasers of carbon fiber. In January 2002, these were consolidated into a case captioned Carbon Fiber Cases I, II, and III, Judicial Council Coordination Proceeding Nos. 4212, 4216 and 4222, Superior Court of California, County of San Francisco. These actions all allege violations of the California Business and Professions Code relating to alleged price fixing of carbon fiber and unfair competition. The Company denies liability and will vigorously defend each of these actions.
In June 2002, a purported class action was filed in Massachusetts under the caption Saul M. Ostroff, et al. v. Newport Adhesives, et al., Civil Action No. 02-2385, Superior Court of Middlesex County. This matter is a purported class action brought on behalf of consumers who purchased merchandise manufactured with carbon fiber, and alleges the same types of price fixing activities alleged in the actions described in the above two paragraphs. In October 2002, the Company was notified that Horizon Sports Technologies had "opted out" of the federal antitrust class action described above (Thomas & Thomas Rodmakers) and filed its own suit against Hercules and the other defendants in that action (Horizon Sports Technologies, Inc. v. Newport Adhesives and Composites, Inc., et al., Case No. CV02-8126 FMC (RNEX), U.S. District Court, Central District of California, Western Division).
Further, in April 2002, a related "Qui Tam" action was unsealed by the U.S. District Court for the Southern District of California. That action is captioned Randall M. Beck, et al. v. Boeing Defense and Space Group, Inc., et al., (Civil Action No. 99 CV 1557 JM JAH), was filed under seal in 1999, and is a "False Claims" action brought pursuant to the False Claims Act (31 U.S.C. Section 729 et seq.). In that action, the relators, in the name of the United States Government, allege the same price fixing activities which are the subject of the above-described actions. The relators then allege that those alleged price fixing activities resulted in inflated prices being charged by the defendant carbon fiber manufacturers to the defendant defense contractors, who, in turn, submitted claims for payment to the United States Government under various government contracts. It is alleged that those claims for payment were "false claims" because the prices charged for the carbon fiber and carbon prepreg were "f ixed" contrary to the laws of the United States. By Order dated November 14, 2002, the Court dismissed the relators' complaint without prejudice because the complaint did not meet certain pleading requirements under the Federal Rules of Civil Procedure. The relators filed a First Amended Complaint on January 3, 2003. By Order dated July 29, 2003, the Court dismissed the First Amended Complaint without prejudice for similar reasons and provided the relators thirty days to re-file their complaint. The Company denies liability and will vigorously defend each of these actions.
In connection with the grand jury investigation noted above in the paragraph describing the Cape Composites litigation, in January 2000, the United States Department of Justice ("DOJ"), Antitrust Division, served a grand jury subpoena duces tecum upon Hercules. The Company has been advised that it is one of several manufacturers of carbon fiber and carbon prepreg that have been served with such a subpoena.
On September 28, 2000, the Company sold its Food Gums Division to CP Kelco ApS, a joint venture that the Company entered into with Lehman Brothers Merchant Banking Partners II, L.P. CP Kelco also acquired the biogums business of Pharmacia Corporation (formerly Monsanto Company). In April 2001, CP Kelco U.S., Inc., a wholly-owned subsidiary of CP Kelco ApS sued Pharmacia (CP Kelco U.S., Inc. v. Pharmacia Corporation U.S. District Court for the District of Delaware, Case No. 01-240-RRM), alleging federal securities fraud, common law fraud, breach of warranties and representations, and equitable fraud. In essence, the lawsuit alleged that Pharmacia misrepresented the value of the biogums business, resulting in damages to CP Kelco U.S., including the devaluation of CP Kelco U.S.'s senior debt by the securities markets. In June 2001, Pharmacia filed a third-party complaint against the Company and Lehman. That complaint sought contribution and indemnification from the Company and Lehman, jointly and severally, for any damages that may be awarded to CP Kelco U.S. in its action against Pharmacia. The Company filed a Motion for Judgment on the Pleadings, which was granted by the Magistrate Judge on September 19, 2002. In March 2003, the Magistrate Judge's ruling was adopted by the District Court judge. Prior to a trial on the case-in-chief, the District Court dismissed the Company from the case, subject to Pharmacia's right to appeal. On April 28, 2003, a jury trial began on the case-in-chief among CP Kelco, Lehman and Pharmacia. After the commencement of jury deliberations, the parties reached a settlement. The terms of the settlement are confidential. As a result of the settlement, this matter is concluded.
In November 2002, an action for declaratory judgment was filed in the U.S. District Court for the District of Delaware under the caption of Atofina Chemicals, Inc. and Atofina v. Hercules Incorporated (Civil Action No. 02-1613). In this action, Atofina seeks a declaration from the court regarding its liability for certain damages sought by the Company as compensation for injuries arising from the actions of Atofina, Akzo Nobel Chemicals and Clariant (including its successor in interest, Hoechst Celanese) in fixing the prices of monochloracetic acid and sodium monochloractetate from 1995 to 2000. In response, the Company has counter-claimed against the entities identified above and affiliated companies for damages and injunctive relief. The matter is still in the pleadings stage with discovery to follow. The Company has settled with some of the parties. The terms of the settlements are confidential.
By Order dated May 6, 2003, the U.S. District Court for the Middle District of Louisiana remanded to the 18th Judicial District Court for the Parish of Iberville, Louisiana, a total of nine (9) consolidated lawsuits, including two (2) lawsuits in which the Company is a defendant. These two lawsuits are Jerry Oldham, et al. v. The State of Louisiana, et al., Civil Action No. 55,160, 18th Judicial District Court, Parish of Iberville, Louisiana and John Capone, et al. v. The State of Louisiana, et al., Civil Action No. 56,048C, 18th Judicial District Court, Parish of Iberville, Louisiana, were served on the Company in September 2002 and October 2002, respectively. The Oldham case is a purported class action comprised of as many as 4,000 plaintiffs, and the Capone case is a consolidated action by approximately 44 plaintiffs. Both actions assert claims against the State of Louisiana, the Company, American PetroFina, Hercofina, Ashland Oil, International Minerals and Chemicals, Allem ania Chemical, Ashland Chemical and the Parish of Iberville. The purported class members and plaintiffs, who claim to have worked or lived at or around the Georgia Gulf plant in Iberville Parish, allege injury and fear of future illness from the consumption of contaminated water and, specifically, elevated levels of arsenic in that water. As to the Company, plaintiffs allege that the Company, itself, and then as part of a joint venture, operated a nearby plant and, as part of those operations, used a groundwater injection well to dispose of various wastes, and that those wastes contaminated the potable water supply at Georgia Gulf. On October 17, 2002, the Company removed these matters to federal court. In January 2003, the U.S. District Court for the Middle District of Louisiana consolidated the Capone and Oldham matters with other lawsuits in which the Company is not a party. Plaintiffs sought remand which, as noted above, was granted by Order dated May 6, 2003. Discovery is now beginning. Th e Company denies any liability and intends to vigorously defend these matters.
On January 31, 2003, the Court granted a Motion for Class Certification in a lawsuit captioned Douglas C. Smith, Individually and on Behalf of All Others Similarly Situated v. Hercules Incorporated and Thomas Gossage, CA No. 01C-08-291 WCC, Superior Court of Delaware, New Castle County. This lawsuit, which was filed on August 31, 2001, on behalf of Mr. Smith and a class of approximately 130 present and former Hercules employees, seeks payments under the "Integration Synergies Incentive Compensation Plan" (the "Plan"), a program put into place by the Company following its acquisition of BetzDearborn Inc. in October 1998. The goal of the Plan was to provide certain financial incentives to specific employees who were deemed to have significant impact on the integration of BetzDearborn Inc. into Hercules Incorporated. The amount to be paid under the Plan was tied to the successful achievement of "synergies," which were defined as the annualized reduction of expenses or improvement of profits realized a s a result of the integration of BetzDearborn Inc. into Hercules. The lawsuit essentially alleges that the payments made under the Plan were not adequate and that the Company breached the terms of the Plan. The lawsuit seeks payments of between $25 million and $30 million, although the Company does not believe that any payments are owed to the class members. In February 2003, plaintiffs agreed to dismiss Thomas Gossage from the lawsuit. In June 2003, potential members who had previously signed releases in favor of the Company were provided an opportunity to "opt in" to the class, and the remaining class members were provided an opportunity to "opt out" of the class. As a result of this process, the size of the class has been reduced to approximately 87 members and, as a result, the maximum potential damages payable to the class, should plaintiffs prevail, should be significantly lower than the amounts noted above. Discovery is ongoing. The Company denies any liability to the plaintiffs and is vigorously defe nding this action.
Agent Orange is a defoliant that was manufactured by several companies, including Hercules, at the direction of the United States Government, and used by the United States Government in both Korea and Vietnam, primarily from 1965 to 1970. In 1984, as part of a class action settlement, the Company and other defendants settled the claims of persons who were in the United States, New Zealand and Australian Armed Forces who alleged injury due to exposure to Agent Orange. In Re "Agent Orange" Prod. Liab. Litig., 597 F. Supp. 740 (E.D.N.Y. 1984). Following that settlement, all claims for alleged injuries due to exposure to Agent Orange by persons who had served in the Armed Forces of those countries were treated as covered by that class action settlement. On June 9, 2003, the United States Supreme Court affirmed the decision of the United States Court of Appeals for the Second Circuit in a case captioned Dow Chemical Company, et al. v. Daniel Raymond Stephenson, et al., 123 S. Ct. 2161 (2003), and, as a result, the claims of persons who allege injuries due to exposure to Agent Orange and whose injuries first manifest themselves after exhaustion of the settlement fund created through the 1984 class action settlement may no longer be barred by the 1984 class action settlement. As a result, such persons may now be able to pursue claims against the Company and the other former manufacturers of Agent Orange. At this time, the Company is a defendant in fewer than ten lawsuits (including one purported class action) where plaintiffs allege that exposure to Agent Orange caused them to sustain various personal injuries. Despite the recent ruling by the United States Supreme Court, the Company believes that it has substantial meritorious defenses to these claims, denies any liability to plaintiffs and will vigorously defend all actions now pending or that may be brought in the future.
The Company has been notified by the IRS that it will be receiving a Notice of Deficiency with respect to the Company's 1996 through 1998 federal income tax returns wherein the IRS is disallowing a capital loss that the Company carried back to 1996 and 1997. The IRS has indicated that it will not settle the issue prior to a final decision after trial on the matter. The Company believes that it is remote that ultimate disposition of this matter will have a material impact on the Company's financial position.
At June 30, 2003, the consolidated balance sheet reflects a current liability of approximately $25 million and a long-term liability of approximately $180 million for litigation and claims. These amounts represent management's best estimate of the probable and reasonably estimable losses related to litigation or claims. The extent of the liability and recovery is evaluated quarterly. While it is not feasible to predict the outcome of all pending suits and claims, the ultimate resolution of these matters could have a material effect upon the financial position of Hercules, and the resolution of any of the matters during a specific period could have a material effect on the quarterly or annual operating results for that period.
The table below reflects Net sales and Profit from operations for the three and six months ended June 30, 2003 and 2002.
(Dollars in millions) |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||
2003 |
2002 |
2003 |
2002 |
||||
Net sales: |
|||||||
Performance Products |
$ 384 |
$ 356 |
$ 740 |
$ 683 |
|||
Engineered Materials and Additives |
88 |
81 |
173 |
156 |
|||
Consolidated |
$ 472 |
$ 437 |
$ 913 |
$ 839 |
|||
Profit from operations: |
|||||||
Performance Products |
$ 72 |
$ 62 |
$ 128 |
$ 120 |
|||
Engineered Materials and Additives |
2 |
3 |
4 |
6 |
|||
Corporate Items (a) |
(1) |
(12) |
- |
(19) |
|||
Consolidated |
$ 73 |
$ 53 |
$ 132 |
$ 107 |
|||
The effective tax rate for the quarter for continuing operations was 14% versus 28% for the same period 2002. The rate for the quarter was favorably impacted by a tax benefit resulting from the donation of intellectual property to a qualified organization. The effective tax rate for the quarter without the donation of the intellectual property would have been 35%. The anticipated full year 2003 tax rate is approximately 31%, net of the tax benefit from the donation of the intellectual property. Excluding the tax benefit from the donation of the intellectual property, the full year 2003 tax rate would be approximately 36%.
The following condensed consolidating financial information for the Company presents the financial information of Hercules, the guarantor subsidiaries and the non-guarantor subsidiaries based on the Company's understanding of the Securities and Exchange Commission's interpretation and application of Rule 3-10 under the Securities and Exchange Commission's Regulation S-X. The financial information may not necessarily be indicative of results of operations or financial position had the guarantor subsidiaries or non-guarantor subsidiaries operated as independent entities.
In this presentation, Hercules consists of the parent company's operations. Guarantor subsidiaries and non-guarantor subsidiaries of Hercules are reported on an equity basis.
Condensed Consolidating Statement of Operations |
|||||||||
Three Months Ended June 30, 2003 |
(Unaudited) |
||||||||
(Dollars in millions) |
|||||||||
Unconsolidated |
|||||||||
Guarantor |
Non-Guarantor |
Eliminations & |
|||||||
Parent |
Subsidiaries |
Subsidiaries |
Adjustments |
Consolidated |
|||||
Net sales |
$ 130 |
$ 110 |
$ 263 |
$ (31) |
$ 472 |
||||
Cost of sales |
84 |
77 |
166 |
(32) |
295 |
||||
Selling, general, and administrative expenses |
27 |
22 |
42 |
- |
91 |
||||
Research and development |
4 |
4 |
1 |
- |
9 |
||||
Intangible asset amortization |
1 |
1 |
- |
- |
2 |
||||
Other operating expense, net |
1 |
- |
1 |
- |
2 |
||||
Profit from operations |
13 |
6 |
53 |
1 |
73 |
||||
Interest and debt expense (income), net |
43 |
(14) |
(10) |
- |
19 |
||||
Preferred security distributions of subsidiary trusts |
- |
- |
14 |
- |
14 |
||||
Other expense, net |
6 |
- |
- |
- |
6 |
||||
(Loss) income before income taxes and equity income |
(36) |
20 |
49 |
1 |
34 |
||||
(Benefit) provision for income taxes |
(17) |
9 |
13 |
- |
5 |
||||
Equity income of affiliated companies, net of tax |
- |
1 |
- |
- |
1 |
||||
Equity income from consolidated subsidiaries |
49 |
4 |
- |
(53) |
- |
||||
Net income from continuing operations before discontinued |
|||||||||
operations and cumulative effect of changes in accounting principle |
30 |
16 |
36 |
(52) |
30 |
||||
Net income from discontinued operations, net of tax |
2 |
- |
- |
- |
2 |
||||
Net income before cumulative effect of changes in |
|||||||||
accounting principle |
32 |
16 |
36 |
(52) |
32 |
||||
Cumulative effect of changes in accounting principle, net of tax |
- |
- |
- |
- |
- |
||||
Net income |
$ 32 |
$ 16 |
$ 36 |
$ (52) |
$ 32 |
Condensed Consolidating Statement of Operations |
|||||||||
Three Months Ended June 30, 2002 |
(Unaudited) |
||||||||
(Dollars in millions) |
|||||||||
Unconsolidated |
|||||||||
Guarantor |
Non-Guarantor |
Eliminations & |
|||||||
Parent |
Subsidiaries |
Subsidiaries |
Adjustments |
Consolidated |
|||||
Net sales |
$ 138 |
$ 110 |
$ 226 |
$ (37) |
$ 437 |
||||
Cost of sales |
87 |
75 |
142 |
(37) |
267 |
||||
Selling, general, and administrative expenses |
24 |
13 |
47 |
- |
84 |
||||
Research and development |
5 |
4 |
2 |
- |
11 |
||||
Intangible asset amortization |
2 |
1 |
- |
- |
3 |
||||
Other operating expense, net |
8 |
3 |
8 |
- |
19 |
||||
Profit from operations |
12 |
14 |
27 |
- |
53 |
||||
Interest and debt expense (income), net |
52 |
(17) |
(10) |
- |
25 |
||||
Preferred security distributions of subsidiary trusts |
- |
- |
14 |
- |
14 |
||||
Other (expense) income, net |
(46) |
- |
- |
1 |
(45) |
||||
(Loss) income before income taxes and equity income (loss) |
(86) |
31 |
23 |
1 |
(31) |
||||
(Benefit) provision for income taxes |
(21) |
11 |
1 |
- |
(9) |
||||
Equity income of affiliated companies, net of tax |
- |
1 |
- |
- |
1 |
||||
Equity income (loss) from consolidated subsidiaries |
44 |
23 |
2 |
(69) |
- |
||||
Net (loss) income from continuing operations before discontinued operations and cumulative effect of changes in accounting principle |
(21) |
44 |
24 |
(68) |
(21) |
||||
Net income from discontinued operations, net of tax |
10 |
6 |
3 |
(9) |
10 |
||||
Net (loss) income before cumulative effect of changes in |
|||||||||
accounting principle |
(11) |
50 |
27 |
(77) |
(11) |
||||
Cumulative effect of changes in accounting principle, net of tax |
- |
- |
- |
- |
- |
||||
Net (loss) income |
$ (11) |
$ 50 |
$ 27 |
$ (77) |
$ (11) |
Condensed Consolidating Statement of Operations |
||||||||||
Six Months Ended June 30, 2003 |
||||||||||
(Unaudited) |
||||||||||
(Dollars in millions) |
||||||||||
Unconsolidated |
||||||||||
Guarantor |
Non-Guarantor |
Eliminations & |
||||||||
Parent |
Subsidiaries |
Subsidiaries |
Adjustments |
Consolidated |
||||||
Net sales |
$ 259 |
$ 217 |
$ 497 |
$ (60) |
$ 913 |
|||||
Cost of sales |
167 |
153 |
315 |
(59) |
576 |
|||||
Selling, general, and administrative expenses |
55 |
37 |
89 |
- |
181 |
|||||
Research and development |
9 |
8 |
2 |
- |
19 |
|||||
Intangible asset amortization |
3 |
1 |
- |
- |
4 |
|||||
Other operating (income) expense, net |
(1) |
- |
2 |
- |
1 |
|||||
Profit from operations |
26 |
18 |
89 |
(1) |
132 |
|||||
Interest and debt expense (income), net |
88 |
(29) |
(21) |
- |
38 |
|||||
Preferred security distributions of subsidiary trusts |
- |
- |
29 |
- |
29 |
|||||
Other expense, net |
7 |
2 |
1 |
- |
10 |
|||||
(Loss) before income taxes and equity income |
(69) |
45 |
80 |
(1) |
55 |
|||||
(Benefit) provision for income taxes |
(28) |
18 |
23 |
- |
13 |
|||||
Equity income of affiliated companies, net of tax |
- |
1 |
- |
- |
1 |
|||||
Equity income from consolidated subsidiaries |
84 |
7 |
1 |
(92) |
- |
|||||
Net income from continuing operations before discontinued |
||||||||||
operations and cumulative effect of changes in accounting principle |
43 |
35 |
58 |
(93) |
43 |
|||||
Net income from discontinued operations, net of tax |
2 |
- |
- |
- |
2 |
|||||
Net income before cumulative effect of changes in |
||||||||||
accounting principle |
45 |
35 |
58 |
(93) |
45 |
|||||
Cumulative effect of changes in accounting principle, net of tax |
(28) |
- |
- |
- |
(28) |
|||||
Net income |
$ 17 |
$ 35 |
$ 58 |
$ (93) |
$ 17 |
Condensed Consolidating Statement of Operations |
|||||||||||||||||||
Six Months Ended June 30, 2002 |
|||||||||||||||||||
(Unaudited) |
|||||||||||||||||||
(Dollars in millions) |
|||||||||||||||||||
Unconsolidated |
|||||||||||||||||||
Parent |
Guarantor Subsidiaries |
Non-Guarantor Subsidiaries |
Eliminations & Adjustments |
Consolidated |
|||||||||||||||
Net sales |
$ 271 |
$ 225 |
$ 426 |
$ (83) |
$ 839 |
||||||||||||||
Cost of sales |
171 |
156 |
266 |
(83) |
510 |
||||||||||||||
Selling, general, and administrative expenses |
44 |
39 |
89 |
- |
172 |
||||||||||||||
Research and development |
10 |
8 |
3 |
- |
21 |
||||||||||||||
Intangible asset amortization |
3 |
2 |
- |
- |
5 |
||||||||||||||
Other operating expense, net |
7 |
7 |
10 |
- |
24 |
||||||||||||||
Profit from operations |
36 |
13 |
58 |
- |
107 |
||||||||||||||
Interest and debt expense (income), net |
120 |
(40) |
(19) |
- |
61 |
||||||||||||||
Preferred security distributions of subsidiary trusts |
- |
- |
29 |
- |
29 |
||||||||||||||
Other (expense) income, net |
(47) |
(1) |
(2) |
1 |
(49) |
||||||||||||||
- |
|||||||||||||||||||
Loss (income) before income taxes and equity income (loss) |
(131) |
52 |
46 |
1 |
(32) |
||||||||||||||
(Benefit) provision for income taxes |
(32) |
19 |
6 |
- |
(7) |
||||||||||||||
Equity income of affiliated companies, net of tax |
- |
1 |
- |
- |
1 |
||||||||||||||
Equity income (loss) from consolidated subsidiaries |
75 |
38 |
3 |
(116) |
- |
||||||||||||||
Net (loss) income from continuing operations before discontinued operations and cumulative effect of changes in accounting principle |
(24) |
72 |
43 |
(115) |
(24) |
||||||||||||||
Net (loss) income from discontinued operations, net of tax |
(199) |
18 |
13 |
(31) |
(199) |
||||||||||||||
Net (loss) income before cumulative effect of changes in accounting principle |
(223) |
90 |
56 |
(146) |
(223) |
||||||||||||||
Cumulative effect of changes in accounting principle, net of tax |
(368) |
- |
- |
- |
(368) |
||||||||||||||
Net (loss) income |
$ (591) |
$ 90 |
$ 56 |
$ (146) |
$ (591) |
Condensed Consolidating Balance Sheet |
|
|
|
|
|
|
|
|
|
||||
June 30, 2003 |
Unaudited |
||||||||||||
|
(Dollars in millions) |
||||||||||||
|
Unconsolidated |
|
|
|
|
||||||||
|
Parent |
|
Guarantor Subsidiaries |
|
Non-Guarantor Subsidiaries |
|
Eliminations & Adjustments |
|
Consolidated |
||||
Assets |
|
|
|
|
|
|
|
|
|
||||
Current assets |
|||||||||||||
Cash and cash equivalents |
$ 48 |
|
$ 6 |
|
$ 117 |
|
$ - |
|
$ 171 |
||||
Restricted cash |
- |
|
- |
|
- |
|
- |
|
- |
||||
Accounts and notes receivable, net |
94 |
|
67 |
|
236 |
|
- |
|
397 |
||||
Intercompany receivables |
81 |
|
26 |
|
28 |
|
(135) |
|
- |
||||
Inventories |
49 |
|
57 |
|
87 |
|
(11) |
|
182 |
||||
Deferred income taxes |
27 |
|
17 |
|
3 |
|
- |
|
47 |
||||
Total current assets |
299 |
173 |
471 |
(146) |
797 |
||||||||
Property, plant, and equipment, net |
171 |
157 |
347 |
- |
675 |
||||||||
Investments in subsidiaries |
2,320 |
74 |
51 |
(2,445) |
- |
||||||||
Goodwill and other intangible assets, net |
230 |
|
90 |
|
372 |
|
- |
|
692 |
||||
Deferred income taxes |
121 |
|
- |
|
17 |
|
(121) |
|
17 |
||||
Other assets |
347 |
|
9 |
|
70 |
|
- |
|
426 |
||||
Total assets |
$ 3,488 |
$ 503 |
$ 1,328 |
$ (2,712) |
$ 2,607 |
||||||||
Liabilities and Stockholders' (Deficit) Equity |
|||||||||||||
Current liabilities |
|
|
|
|
|
|
|
|
|
||||
Accounts payable |
$ 45 |
|
$ 24 |
|
$ 103 |
|
$ - |
|
$ 172 |
||||
Accrued expenses |
63 |
|
106 |
|
62 |
|
- |
|
231 |
||||
Intercompany payables |
10 |
|
78 |
|
47 |
|
(135) |
|
- |
||||
Short-term debt |
2 |
|
- |
|
19 |
|
- |
|
21 |
||||
Total current liabilities |
120 |
208 |
231 |
(135) |
424 |
||||||||
Long-term debt |
700 |
|
- |
|
32 |
|
- |
|
732 |
||||
Deferred income taxes |
- |
|
120 |
|
78 |
|
(121) |
|
77 |
||||
Postretirement benefits and other liabilities |
617 |
|
85 |
|
62 |
|
- |
|
764 |
||||
Company-obligated preferred securities of subsidiary trusts |
- |
|
- |
|
625 |
|
- |
|
625 |
||||
Intercompany notes payable/(receivable) |
2,066 |
|
(1,084) |
|
(982) |
|
- |
|
- |
||||
Stockholders' (deficit) equity |
(15) |
|
1,174 |
|
1,282 |
|
(2,456) |
|
(15) |
||||
Total liabilities and stockholders' equity (deficit) |
$ 3,488 |
|
$ 503 |
|
$ 1,328 |
|
$ (2,712) |
|
$ 2,607 |
Condensed Consolidating Statement of Cash Flows |
||||||||||||
Six Months Ended June 30, 2003 |
||||||||||||
(Unaudited) |
||||||||||||
(Dollars in millions) |
||||||||||||
Unconsolidated |
||||||||||||
Guarantor |
Non-Guarantor |
|||||||||||
Parent |
Subsidiaries |
Subsidiaries |
Eliminations |
Consolidated |
||||||||
Net Cash (Used In) Provided By Operations |
$ (41) |
$ 57 |
$ 42 |
$ (90) |
$ (32) |
|||||||
Cash Flow From Investing Activities: |
||||||||||||
Capital expenditures |
(5) |
(6) |
(8) |
- |
(19) |
|||||||
Proceeds of investment and fixed asset disposals |
- |
- |
3 |
- |
3 |
|||||||
Decrease in restricted cash |
125 |
- |
- |
- |
125 |
|||||||
Other, net |
(1) |
1 |
(4) |
- |
(4) |
|||||||
Net cash provided by (used in) investing activities |
119 |
(5) |
(9) |
- |
105 |
|||||||
Cash Flow From Financing Activities: |
||||||||||||
Long-term debt repayments |
(126) |
- |
(7) |
- |
(133) |
|||||||
Change in short-term debt |
- |
- |
(1) |
- |
(1) |
|||||||
Change in intercompany, noncurrent |
(49) |
(53) |
12 |
90 |
- |
|||||||
Common stock issued |
14 |
- |
- |
- |
14 |
|||||||
Net cash (used in) provided by financing activities |
(161) |
(53) |
4 |
90 |
(120) |
|||||||
Effect of exchange rate changes on cash |
- |
- |
9 |
- |
9 |
|||||||
Net (decrease) increase in cash and cash equivalents |
(83) |
(1) |
46 |
- |
(38) |
|||||||
Cash and cash equivalents at beginning of period |
131 |
7 |
71 |
- |
209 |
|||||||
Cash and cash equivalents at end of period |
$ 48 |
$ 6 |
$ 117 |
$ - |
$ 171 |
|||||||
Condensed Consolidating Statement of Cash Flows |
|||||||||
Six Months Ended June 30, 2002 |
|||||||||
(Unaudited) |
|||||||||
(Dollars in millions) |
|||||||||
Unconsolidated |
|||||||||
Guarantor |
Non-Guarantor |
||||||||
Parent |
Subsidiaries |
Subsidiaries |
Eliminations |
Consolidated |
|||||
Net Cash (Used In) Provided by Operating Activities of Continuing Operations |
$ (414) |
$ (167) |
$ 153 |
$ 125 |
$ (303) |
||||
Cash Flow From Investing Activities: |
|||||||||
Capital expenditures |
(6) |
(3) |
(4) |
- |
(13) |
||||
Proceeds of investment and fixed asset disposals |
1,810 |
- |
1 |
- |
1,811 |
||||
Other, net |
- |
- |
4 |
- |
4 |
||||
Net cash provided by (used in) investing activities of continuing operations |
1,804 |
(3) |
1 |
- |
1,802 |
||||
Cash Flow From Financing Activities: |
|||||||||
Long-term debt proceeds |
250 |
- |
- |
- |
250 |
||||
Long-term debt repayments |
(1,692) |
(5) |
(73) |
- |
(1,770) |
||||
Change in short-term debt |
- |
- |
(8) |
- |
(8) |
||||
Change in intercompany, noncurrent |
65 |
165 |
(105) |
(125) |
- |
||||
Common stock issued |
4 |
- |
- |
- |
4 |
||||
Net cash (used in) provided by financing activities of continuing operations |
(1,373) |
160 |
(186) |
(125) |
(1,524) |
||||
Net cash flow provided by discontinued operations |
- |
5 |
20 |
- |
25 |
||||
Effect of exchange rate changes on cash |
- |
- |
(4) |
- |
(4) |
||||
Net increase (decrease) in cash and cash equivalents |
17 |
(5) |
(16) |
- |
(4) |
||||
Cash and cash equivalents at beginning of period |
8 |
12 |
56 |
- |
76 |
||||
Cash and cash equivalents at end of period |
$ 25 |
$ 7 |
$ 40 |
$ - |
$ 72 |
||||
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Within the following discussion, unless otherwise stated, "quarter" and "six-month period" refer to the second quarter of 2003 and the six months ended June 30, 2003. All comparisons are with the corresponding period in the previous year, unless otherwise stated.
The Company operates through two reportable segments and four divisions: Performance Products (Pulp and Paper, Aqualon) and Engineered Materials and Additives (FiberVisions, Pinova).
The table below reflects Net sales and Profit from operations for the three and six-month period ended June 30, 2003 and 2002. Substantially all corporate items have been allocated to the segments. Corporate items primarily include corporate expenses.
(Dollars in millions) |
Three Months Ended |
Six Months Ended |
|||||
June 30, |
June 30, |
||||||
2003 |
2002 |
2003 |
2002 |
||||
Net sales: |
|||||||
Performance Products |
$ 384 |
$ 356 |
$ 740 |
$ 683 |
|||
Engineered Materials and Additives |
88 |
81 |
173 |
156 |
|||
Consolidated |
$ 472 |
$ 437 |
$ 913 |
$ 839 |
|||
Profit from operations: |
|||||||
Performance Products |
$ 72 |
$ 62 |
$ 128 |
$ 120 |
|||
Engineered Materials and Additives |
2 |
3 |
4 |
6 |
|||
Corporate Items (a) |
(1) |
(12) |
- |
(19) |
|||
Consolidated |
$ 73 |
$ 53 |
$ 132 |
$ 107 |
(a) Corporate items for the three and six months ended June 30, 2003 include severance charges, income recognized as a result of a favorable legal settlement and charges relating to the resolution of prior year business divestitures. Corporate items for the three and six months ended June 30, 2002 include restructuring charges, environmental costs and other corporate costs not allocated to the businesses.
Consolidated net sales were $472 million for the quarter, an increase of $35 million, or 8%, and $913 million for the six-month period, an increase of $74 million, or 9%. Compared to the second quarter 2002, sales increased primarily due to the positive impact of the weaker dollar versus the euro and also to higher volumes in Aqualon and FiberVisions. In the six-month period, prices were flat while volume/mix and rate of exchange had positive impacts. Regionally, net sales improved 23% in Europe and 6% in Asia Pacific, remained flat in Latin America and declined 1% in North America for the quarter. In the six-month period, net sales improved 1% in North America, 24% in Europe and 10% in Asia Pacific and declined 6% in Latin America. European sales were higher primarily due to the positive impact of the weaker dollar versus the euro. Profit from operations improved $20 million, or 38%, and $25 million, or 23%, for the quarter and six-month period, respectively. The improvement in profit from operations was driven by the positive impact of the weaker dollar versus the euro and reductions in the Company's fixed cost structure pursuant to the comprehensive cost reduction and Work Process Redesign program (see Note 10) commenced in 2001; offsetting these amounts were higher raw material and energy costs, higher insurance expenses and higher pension and postretirement costs. Profit from operations benefited from lower environmental and severance charges and the absence of an asset impairment charge versus the prior year.
In the Performance Products segment, net sales grew $28 million, or 8%, and $57 million, or 8%, for the quarter and six-month period, respectively. Profit from operations increased $10 million, or 16%, for the quarter and $8 million, or 7%, for the six-month period. In the Pulp and Paper Division, net sales growth resulted primarily from the positive impact of rate of exchange and growth in China and Brazil, partially offset by lower volume/mix in North America and Europe. Profit from operations in the quarter and six-month period was negatively impacted by lower volume/mix, higher costs for energy, freight and raw materials and higher pension expenses partially offset by the positive impact of rate of exchange and lower costs as a result of the cost reduction and Work Process Redesign program. Profit from operations benefited from the absence of an asset impairment charge in the quarter and six-month period versus the prior year periods. Aqualon experienced 13% net sales growth in both the quarter and si x-month period. Net sales improved due to favorable rate of exchange, higher volumes and slightly higher prices. Profit from operations improved 18% and 13%, respectively, for the quarter and six-month period. These improvements were primarily due to higher volumes and the positive effect of rate of exchange. Volume improvements are attributable to increased oilfield demand as rig counts were up worldwide versus the prior year as well as increased sales from new business. Profit from operations was negatively impacted by higher pension expenses.
In the Engineered Materials and Additives segment, net sales increased $7 million, or 9%, for the quarter and improved $17 million, or 11%, for the six-month period. Profit from operations declined $1 million and $2 million for the quarter and six-month period, respectively. FiberVisions net sales increased 20% and 23% for the quarter and six-month period, respectively. Net sales growth resulted from the positive rate of exchange effect, the contractual customer pass through of higher polymer costs and higher volumes for the quarter and six-month period, respectively. Higher volumes were a result of increased demand in the wipes and baby diapers markets. Profit from operations improved by $2 million for both the quarter and six-month period as a result of increased volumes, the positive effect of rate of exchange and higher prices partially offset by higher polymer costs. FiberVisions can recover approximately 75% of the higher polymer costs with a four to eight week lag depending on the terms of the cust omer contract. Conversely, when polymer prices begin to decline, the lag results in margin recovery. Net sales in Pinova experienced a 15% and 14% decline for the quarter and six-month period, respectively, as a result of 17% and 12% lower volumes in the corresponding periods. Pinova's decreased volumes were due to lost sales from competitive pricing in the chewing gum and adhesive markets. Profit from operations decreased $3 million and $4 million, respectively, as a result of lower volumes, higher pension and energy costs and negative fixed cost absorption.
Selling, general and administration expenses increased $7 million for the quarter and $9 million for the six-month period. The increase in both periods is primarily due to the stronger euro, which accounted for $6 million and $11 million, respectively, for the quarter and six-month period.
Interest and debt expense, and preferred security distributions of subsidiary trusts decreased $6 million for the quarter and $23 million for the six-month period, primarily due to lower outstanding debt balances, reflecting the application of proceeds from the sale of the Water Treatment Business on April 29, 2002.
The effective tax rate for the quarter for continuing operations was 14% versus 28% for the same period 2002. The rate for the quarter was favorably impacted by a tax benefit resulting from the donation of intellectual property to a qualified organization. The anticipated full year 2003 tax rate is approximately 31%, net of the tax benefit from the donation of the intellectual property. Excluding the tax benefit from the donation of the intellectual property, the full year 2003 tax rate would be approximately 36%.
Discontinued Operations
On April 29, 2002, Hercules completed the sale of the Water Treatment Business to GE Specialty Materials, a unit of General Electric Company (see Note 4). The sale price was $1.8 billion in cash, resulting in net after-tax proceeds of approximately $1.7 billion. The Company used the net proceeds to prepay debt under its senior credit facility and ESOP credit facility. Pursuant to SFAS 144, the Water Treatment Business was treated as a discontinued operation as of February 12, 2002, and accordingly, all financial information was restated. The loss from discontinued operations for the three months ended March 31, 2002 includes an after-tax loss on the disposal of the business of $230 million. In the three and six months ended June 30, 2003, the Company recognized $2 million in net income relating to discontinued operations as a result of resolving issues relating to the divestiture of the Water Treatment Business.
The Paper Process Chemicals Business, representing approximately one-third of the business of BetzDearborn Inc. when it was originally acquired in 1998, was fully integrated into and continues to be reported within the Pulp and Paper Division.
Financial Condition
Liquidity and Financial Resources: Net cash flow used in continuing operations was $32 million for the six-month period compared to $303 million in the prior year period. The improvement in cash flow used in operations in 2003 versus 2002 is a result of improved cash flow generated by the businesses, lower restructuring payments, lower interest payments, lower pension contributions and significantly lower tax payments in 2003 versus the prior year. Additionally, in 2002 the Company paid penalties associated with the prepayment of debt with the proceeds from the sale of the Water Treatment Business.
The Company contributed $40 million to its U.S. pension plan in the second quarter 2003. The Company made payments of $63 million, $15 million and $5 million for interest costs, restructuring and asbestos-related costs, respectively, in the six months ended June 30, 2003.
Net cash flow provided by investing activities was $105 million for the six months ended June 30, 2003 and $1,802 million in the six months ended June 30, 2002. In 2003, $125 million of restricted cash was released from an escrow account to repay the $125 million 6.625% notes that matured in June 2003 (see Note 11). Proceeds received from the sale of the Water Treatment Business accounted for the significant cash flow from investing activities in 2002 (see Note 4).
Capital expenditures were $19 million for the first six months of 2003. Capital expenditures are expected to be between $45 million and $58 million during 2003. On April 28, 2003, the Company announced capacity expansion plans for the Natrosol (Registered) HEC (Hydroxyethylcellulose) and Natrosol (Registered) Plus product lines. The expansion, which will be staged at Aqualon's production facilities in New Jersey, Virginia and The Netherlands, is expected to begin in the fourth quarter 2003 and to be completed by the end of 2004. The expansion and upgrades are designed to increase annual capacity by 10,000 tons and have the added capability to produce new products now under development.
Net cash flow used in financing activities was $120 million and $1,524 million, respectively, for the six months ended June 30, 2003 and 2002. In June 2003, the $125 million 6.625% notes matured and were paid with the $125 million in escrowed proceeds from the December 2002 term B loan debt refinancing (see Note 11). In the 2002 period, the Company used cash proceeds from the sale of the Water Treatment Business to pay down long-term debt (see Note 4).
The current ratio has increased to 1.88 at June 30, 2003, compared with 1.47 at December 31, 2002. The quick ratio has increased to 1.34 at June 30, 2003 from 1.13 at December 31, 2002.
As of June 30, 2003, the Company had $55 million available under its $125 million revolving credit agreement and $16 million of unused short-term lines of credit. The Company had outstanding letters of credit associated with the credit facility of $70 million at June 30, 2003. The Company expects to meet short-term cash requirements from current available cash, operating cash flow and availability under lines of credit.
The Company has been advised that the primary and first level excess insurance policies on its asbestos-related matters have largely exhausted, with only minimal limits remaining (see Note 14). The Company has not yet reached agreement with its other insurance carriers to fund the cost of defending and resolving its asbestos-related matters. As a result, until the Company's other insurance carriers begin to fund the cost of defending and resolving these matters, the Company will have to fully fund the cost of defending and settling these matters. In addition to the approximately $5 million, net of insurance reimbursements, spent by the Company in the six-month period, the Company estimates that net cash payments from the Company and cash payments, if any, from its insurers for asbestos-related costs (including defense costs) will approximate $30 million for the remainder of 2003. Nonetheless, based on the current number of claims pending, the amounts the Company anticipates paying to resolve those claims which are not dismissed or otherwise resolved without payment, and anticipated future claims, the Company believes that it and its former subsidiary together have sufficient additional insurance to cover the majority of its current and estimated future asbestos-related liabilities. However, there can be no assurance that such liabilities will be sufficiently covered.
Capital Structure and Commitments: Total capitalization (stockholders' (deficit) equity, company-obligated preferred securities of subsidiary trusts and debt) remained flat at $1.4 billion at June 30, 2003 from year-end 2002. The ratio of debt-to-total capitalization decreased to 55% at June 30, 2003 from 64% at December 31, 2002.
2003 Outlook
The Company has experienced higher pension, health care, insurance, energy and raw material costs than anticipated. Energy and natural gas price spikes caused a number of raw material prices to increase as suppliers used the opportunity to improve margins. It also caused some structural changes and reductions in capacity. The Company expects raw material prices to remain up for some period of time. The Company has mitigated these raw material exposures via supplier consolidation, product substitution and sourcing opportunities in low cost regions such as China, Russia and the former Eastern European states. Pricing softness is beginning to become evident in some cases as a result of the relative moderation in natural gas pricing.
Producers of materials derived from the chlor-alkalai, ethylene and natural gas chains are passing through increases in commodity prices. A combination of market tightness due to capacity consolidation, production interruptions and relative natural gas costs affected many downstream products. Solvents, surfactants and a number of other raw materials came under pressure in the first half of 2003 as suppliers announced price increases. In general, realized increases were well below announced price increases.
The Company raised prices across all four divisions in the first half of 2003, the effects of which were realized beginning in the second quarter.
Demand for paper and paperboard remains sluggish as North American and European producers continue to curtail production to meet demand. Despite weak market conditions, the Company's market share with major multinational paper and paperboard producers has expanded. Over the long-term, the Pulp and Paper Division is forecasting production growth for the global paper industry to be consistent with historical trends. However, the environment continues to be very difficult and requires delivery of total cost savings to customers through new product and application technology.
In Aqualon, market conditions are slightly ahead of last year. Aqualon has seen increases in the oilfield-related businesses. Aqualon has made market share improvements, primarily attributable to new product introductions. Increases to production capacity for key Aqualon products have been initiated.
FiberVisions anticipates no benefit from any economic upturn in 2003. Volume increases were seen in both the hygiene and industrial segments and were due to new product introduction and some gain in market share. Pricing pressure remains high; margin improvement has resulted from polymer price recovery being achieved.
In Pinova, market conditions remain unchanged. Volume is expected to strengthen through the remainder of the year due to new program introductions. Pricing pressure has continued and has been mitigated by the substitution of lower cost alternatives within the Company's product lines to customers.
Recent Events
On March 20, 2003, the Hercules Shareholders' Committee for New Management filed a preliminary proxy statement with the SEC announcing that it would solicit proxies to elect four candidates to the Board of Directors of Hercules Incorporated at the 2003 annual meeting. The Committee was comprised of International Specialty Products Inc., a privately-held international specialty chemicals company, four members of the Hercules Board and the Committee's four nominees for election to the Board of Directors at the annual meeting.
On July 25, 2003, the Hercules Shareholders' Committee for New Management withdrew their nominations to the Company's Board at the annual meeting thereby terminating the proxy contest and announced the resignation of Samuel J. Heyman, Sunil Kumar, Gloria Schaffer and Raymond Troubh from the Board of Directors effective immediately.
As a result, on July 25, 2003 the Company announced that Patrick Duff, Thomas P. Gerrity and John K. Wulff were elected and that Joe B. Wyatt was re-elected to the Board of Directors by the shareholders at the annual meeting.
At the annual meeting, the shareholders also voted on the ratification of PricewaterhouseCoopers LLP as the Company's independent public accountants for 2003, approval of the Hercules Incorporated Omnibus Equity Compensation Plan for Non-Employee Directors, and two shareholders proposals. Final results of the voting will not be available until the independent inspectors of election have completed their review of the voting.
Critical Accounting Policies
The following discussion should be read in connection with the information contained in the Consolidated Financial Statements and Notes thereto. All references to individual Notes refer to Notes to the Consolidated Financial Statements. Certain statements contained herein may constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995.
The Company's discussion and analysis of its financial condition and results of operations is based on its consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires Hercules to make estimates and assumptions that affect the amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Hercules evaluates its estimates on a regular basis, including those related to sales returns and allowances, bad debts, inventories, impairments of long-lived assets, income taxes, restructuring, contingencies, including litigation and environmental, and pension and other benefit obligations. Hercules bases its estimates on various factors including historical experience, consultation and advice from third party subject matter experts and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and circumstances.
Hercules believes the following critical accounting policies affect the more significant judgments and estimates used in the preparation of its consolidated financial statements.
Hercules recognizes revenue when the earnings process is complete, which generally occurs when products are shipped to the customer or services are performed in accordance with the terms of the agreement, title and risk of loss have been transferred, collection is probable and pricing is fixed or determinable. Approximately 12% of the Company's revenues are from consignment inventory. For consignment inventory, title and risk of loss are transferred when the earnings process is considered complete, which generally occurs when the Company's products have been consumed or used in the customer's production process. Hercules records estimated reductions to revenue for customer returns and other allowances, including volume-based incentives and pricing adjustments.
The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. Allowances for doubtful accounts are based on historical experience and known factors regarding specific customers and industries in which the customers operate. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances would be required.
Hercules writes down its inventories for estimated slow moving and obsolete goods by amounts equal to the difference between the carrying cost of the inventory and the estimated market value based upon assumptions about future demand and market conditions.
Aside from goodwill and intangible assets which are tested for impairment under the guidance provided in SFAS 142, the Company has adopted SFAS 144 and tests other long-lived assets for impairment based on the guidance provided in SFAS 144. The Company records an impairment loss on its long-lived assets based on the excess of the carrying amount over fair value, when expected future undiscounted cash flows are insufficient to recover the carrying amount of the asset. The fair value represents expected future cash flows from the use of the assets, discounted at the rate used to evaluate potential investments. If the Company determines that an impairment loss has occurred, the loss is recognized in the income statement. Deterioration in future economic conditions or poor operating results in a business could result in losses or the inability to recover the carrying value of the asset, thereby possibly requiring an impairment in the future.
Effective January 1, 2002, Hercules adopted the provisions of SFAS 142. Hercules identified the following reporting units: BetzDearborn, Pulp and Paper, Aqualon, FiberVisions and Pinova. In connection with Hercules' transitional review, recorded goodwill was determined to be impaired in the BetzDearborn and FiberVisions reporting units. In the first quarter of 2002, Hercules completed its transitional impairment review of the identified reporting units and recognized an after-tax impairment loss of $349 million as a cumulative effect of a change in accounting principle. In addition, an after-tax impairment loss of $19 million was recognized in the first quarter of 2002 relating to the Company's equity investment in CP Kelco, which had an impairment under SFAS 142. Pursuant to SFAS 142, the Company is required to perform an annual assessment of its reporting units for impairment. The annual assessment was performed as of November 30, 2002 and indicated no additional impairment to the Company's goodwil l was warranted.
Hercules records a valuation allowance to reduce its deferred tax assets to an amount that is more likely than not to be realized after consideration of future taxable income and reasonable tax planning strategies. At June 30, 2003, the Company had gross deferred tax assets of approximately $630 million for which it has established valuation allowances of approximately $308 million. In the event that Hercules were to determine that it would not be able to realize all or part of its deferred tax assets for which a valuation allowance has not been established, an adjustment to the deferred tax asset would be charged to income in the period such determination was made.
Hercules has recorded charges for the estimated costs of employee severance and other exit costs. In the third quarter of 2001, the Company initiated a comprehensive cost reduction and Work Process Redesign program to improve return on capital, streamline organizational structure, improve work processes and consolidate manufacturing and non-manufacturing resources. The Company has recognized $76 million in charges pursuant to this initiative since inception, including $68 million for severance and $8 million for other exit costs. During the six months ended June 30, 2003, the accrual for severance and other benefits recognized in accordance with Statement of Financial Accounting Standards No. 112, "Employers' Accounting for Post Employment Benefits," increased by approximately $3 million. In the event that it is determined that additional employees must be involuntarily terminated pursuant to Work Process Redesign and other cost reduction initiatives, additional restructuring reserves would be requir ed, which would result in an additional charge against earnings. In the event that the number of employees involuntarily terminated pursuant to restructuring plans is less than anticipated due to greater than anticipated voluntary resignations, an adjustment to reduce excess restructuring reserves would increase income in the period that the determination was made.
Effective January 1, 2003, the Company adopted SFAS 143 (see Note 13). Adoption of SFAS 143 resulted in the Company increasing the recorded liabilities for environmental remediation obligations. The actual costs for environmental remediation obligations will depend on numerous factors, including the actual methods of remediation required or agreed to, outcomes of negotiations with regulatory authorities, outcomes of litigation, changes in environmental laws and regulations, technological developments, and the years and timing of remedial activity required. SFAS 143 introduced additional variables into the measurement of these obligations, including probability weighting of expected cash flows, present value and assumptions regarding interest rates. Revisions to either the timing or amount of estimated cash flows, as well as the passage of time, will result in changes to the recorded liability.
Hercules establishes reserves for asbestos claims, litigation and other contingencies when it is probable that a liability has been incurred and the amount of the liability is reasonably estimable. At June 30, 2003, the Company had accrued $295 million for contingencies in accordance with Statement of Financial Accounting Standards No. 5, "Accounting for Contingencies" ("SFAS 5"). The actual costs will depend upon numerous factors, including changes in the number or financial exposures of claims, lawsuits, settlements or judgments, or in the ability to reduce such financial exposures by collecting indemnity payments from insurers. If the contingency is resolved for an amount greater or less than has been accrued, or Hercules' share of the contingency increases or decreases, or other assumptions relevant to the development of the estimate were to change, Hercules would recognize an additional expense or benefit in income in the period such determination was made.
The Company provides defined benefit pension and postretirement welfare benefit plans to employees in the United States who meet eligibility requirements. Similar plans are provided outside the United States in accordance with local practice. Pension and other postretirement benefit obligations in the United States and the related expense (income) are determined based upon actuarial assumptions regarding mortality, medical inflation rates, discount rates, long-term return on assets, salary increases, Medicare availability and other factors. The assets of the U.S. defined benefit plan constitute 85% of the total defined benefit plan assets applicable to plans sponsored by the Company. Pursuant to the Company's annual review of the actuarial assumptions, the discount rate was lowered to 6.75% at December 31, 2002 and the expected long-term return on U.S. plan assets was lowered to 8.75% effective January 1, 2003. Based on current assumptions, pension and postretirement benefit plan expenses for the years 20 03, 2004 and 2005 are projected to be approximately $41 million, $69 million and $92 million, respectively. The projected increase in pension expense of $20 to $30 million per year over this time frame is due to the unfavorable performance of the pension investment portfolio over the past three years. As a result of unfavorable economic conditions, the accumulated benefit obligation ("ABO") exceeded the fair value of plan assets at December 31, 2002. At December 31, 2002, the ABO of the U.S., United Kingdom and German defined benefit pension plans, $1,227 million, $55 million and $27 million, respectively, exceeded their funded benefits. Consequently, the Company was required to recognize an additional liability equal to the sum of such excess plus the prepaid pension asset balance, with a corresponding after-tax charge to other comprehensive income in stockholders' equity. The Company recorded a non-cash, after-tax charge to other comprehensive income of $354 million at December 31, 2002. As a result o f this charge, the Company is in a negative net worth position at June 30, 2003. The Company does not believe that this will have any substantial adverse effect on its operations or liquidity. A 100 basis point decrease or increase in the discount rate has approximately a plus or minus $160 million impact on the Company's consolidated ABO. If the U.S. qualified pension plan performs in accordance with the actuarial assumptions, the Company anticipates making cash contributions of approximately $40 million per year over the next 6 to 7 years to maintain compliance with ERISA funding requirements. A government mandated change in minimum funding requirements in the Netherlands may require the Company to make a special contribution to the Dutch pension plan of 5 million euros in 2003.
On January 1, 2003, the Company adopted SFAS 123 as amended by SFAS 148 (see Note 2). SFAS 148 amends SFAS 123 by providing alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation and requiring enhanced disclosure regarding stock-based compensation. As a result, the fair value recognition provisions of SFAS 123 will be applied on a prospective basis to all employee awards granted, modified or settled after January 1, 2003. The Company did not grant any stock-based compensation pursuant to SFAS 123, as amended by SFAS 148, in the first six months of 2003.
Risk Factors
Market Risk - Fluctuations in interest and foreign currency exchange rates affect the Company's financial position and results of operations. The Company uses several strategies from time to time to actively hedge interest rate and foreign currency exchange rate exposure and minimize the effect of such fluctuations on reported earnings and cash flow. Sensitivity of the Company's financial instruments to selected changes in market rates and prices which are reasonably possible are described below. Market values are the present value of projected future cash flows based on the market rates and prices chosen. The market values for interest rate risk are calculated by utilizing a third-party software model that utilizes standard pricing models to determine the present value of the instruments based on the market conditions as of the valuation date.
The Company's derivative and other financial instruments subject to interest rate risk at June 30, 2003 consist of debt instruments, pension benefit obligations and pension plan assets invested in fixed rate securities. The debt instruments had a net market value at June 30, 2003 of $1.4 billion. The sensitivity analysis assumes an instantaneous 100-basis point move in interest rates from their current levels, with all other variables held constant. A 100-basis point increase in interest rates at June 30, 2003 would result in a $69 million decrease in the net market value of the liability. A 100-point decrease in interest rates at June 30, 2003 would result in an $87 million increase in net market value of the liability.
The Company's financial instruments subject to foreign currency exchange risk consist of foreign currency forward contracts and represent a net liability position of $1 million at June 30, 2003. The following sensitivity analysis assumes an instantaneous 10% change in foreign currency exchange rates, with all other variables held constant. A 10% strengthening of the U.S. dollar versus other currencies at June 30, 2003 would result in a $0.1 million increase in the net liability position, while a 10% weakening of the dollar versus other currencies would result in a $0.2 million decrease in the net liability position resulting in a net asset position.
Foreign exchange forward and option contracts have been used to hedge the Company's firm and anticipated foreign currency cash flows. Thus, there is either an asset or cash flow exposure related to all the financial instruments in the above sensitivity analysis for which the impact of a movement in foreign exchange rates would be in the opposite direction and substantially equal to the impact on the instruments in the analysis. There are presently no significant restrictions on the remittance of funds generated by the Company's operations outside the United States.
The Company has not designated any derivative as a hedge instrument under Statement of Financial Accounting Standards No. 133, "Accounting for Derivative Instruments and Hedging Activities," as amended, and accordingly, changes in the fair value of derivatives are recorded each period in earnings.
The assets and liabilities associated with the Company's defined benefit pension plans are subject to interest rate and market risk. At December 31, 2002, the accumulated pension benefit obligation ("ABO") of the U.S., United Kingdom and German defined benefit plans was $1,227 million, $55 million and $27 million, respectively. The fair value of the U.S. defined benefit plan assets at June 30, 2003 was $1,045 million. The assets of the U.S. defined benefit plan are invested as follows: $483 million in domestic corporate equity securities, $198 million in international corporate equity securities, $327 million in fixed income securities and $37 million in other investments. The Company has used an 8.75% assumed rate of return on plan assets for the U.S. plans effective January 1, 2003. A 100-basis point decrease or increase in the discount rate has approximately a plus or minus $130 million impact on the ABO. A 100-basis point decrease or increase in the assumed rate of return has approximately a plus or m inus $12 million impact on the U.S. pension expense estimated for 2003.
Environmental Litigation - Hercules has been identified by U.S. federal and state authorities as a "potentially responsible party" for environmental cleanup at numerous sites. The estimated range of reasonably possible costs for remediation is between $110 million and $220 million. The Company does not anticipate that its financial condition will be materially affected by environmental remediation costs in excess of amounts accrued, although quarterly or annual operating results could be materially effected (see Note 14).
Environmental remediation expenses are funded from internal sources of cash. Such expenses are not expected to have a significant effect on the Company's ongoing liquidity. Environmental cleanup costs, including capital expenditures for ongoing operations, are a normal, recurring part of operations and are not significant in relation to total operating costs or cash flows.
Other Litigation - Hercules is a defendant in numerous lawsuits that arise out of, and are incidental to, the conduct of its business. These suits concern issues such as product liability, contract disputes, employee-related matters, patent infringement, environmental proceedings, property damage and personal injury matters.
The Company is a defendant in numerous asbestos-related personal injury lawsuits and claims which typically arise from alleged exposure to asbestos fibers from resin-encapsulated pipe and tank products which were sold by one of the Company's former subsidiaries to a limited industrial market ("products claims"). The Company is also a defendant in lawsuits alleging exposure to asbestos at facilities formerly or presently owned or operated by the Company ("premises claims"). The Company's estimated liability and insurance recoveries are based on numerous assumptions regarding the number of future claims, the cost of settlements, potential insurance recoveries and other variables. While the Company believes its estimates are reasonable, there can be no assurance that these assumptions will prove to be correct and the Company's actual experience may differ materially over time. Since it is not feasible to predict the outcome of all pending suits and claims, the ultimate resolution of these matters could have a material effect upon the financial position of Hercules, and the resolution of any of the matters during a specific period could have a material effect on the quarterly or annual operating results for that period. The Company has been advised that its primary and first level excess insurance policies have largely exhausted, with only minimal limits remaining. The Company has not yet reached agreement with its other insurance carriers to fund the cost of defending and resolving these matters. As a result, until the Company's other insurance carriers begin to fund the cost of defending and resolving these matters, the Company will have to fully fund the cost of defending and settling these matters. In addition to the approximately $5 million, net of insurance reimbursements, spent by the Company in the six-month period, the Company estimates that net cash payments from the Company and cash payments, if any, from its insurers for asbestos-related costs (including defense costs) will approximate $30 million fo r the remainder of 2003. Nonetheless, based on the current number of claims pending, the amounts the Company anticipates paying to resolve those claims which are not dismissed or otherwise resolved without payment, and anticipated future claims, the Company believes that it and its former subsidiary together have sufficient additional insurance to cover the majority of its current and estimated future asbestos-related liabilities. However, there can be not assurance that such liabilities will be sufficiently covered. On July 10, 2003, the Senate Judiciary Committee approved legislation that would establish a billion dollar trust fund for the compensation of victims of asbestos-related illnesses and sent the bill to the full Senate for approval. If the legislation is enacted in its current form, claimants would be prohibited from bringing their claims to court and would receive compensation for their asbestos exposure, based on the severity of their illness, from the trust fund (see Note 14). There can be no assurance that this or any other similar legislation will be enacted.
Recent Accounting Pronouncements
In January 2003, the Financial Accounting Standards Board ("FASB") issued FASB Interpretation No. 46, "Consolidation of Variable Interest Entities" ("FIN 46") ("VIEs"), which is an interpretation of Accounting Research Bulletin No. 51, "Consolidated Financial Statements" ("ARB 51"). FIN 46 addresses the application of ARB 51 to VIEs, and generally would require that assets, liabilities and results of the activity of a VIE be consolidated into the financial statements of the enterprise that is considered the primary beneficiary. The provisions of FIN 46 apply on a prospective basis to VIEs created after January 31, 2003 and become effective after June 30, 2003 for VIEs the Company had prior to January 31, 2003. The Company currently has two joint-venture VIEs that are presently accounted for using the equity method of accounting. These entities serve as strategic global marketers of the Company's bicomponent fibers. The assets and liabilities of these entities are not consolidated within the Company's financial statements. As of June 30, 2003, the fair value of the assets in these joint ventures was approximately $7 million and the fair values of the associated liabilities and non-controlling interests were approximately $6 million. There are no assets of the Company that serve as collateral for the VIEs and the creditors of the VIEs have no recourse to the general credit of the Company. In addition, the Company has two wholly-owned consolidated subsidiary trusts, Hercules Trust I and Hercules Trust II (jointly, "the Trusts"), which are the issuers of the company-obligated preferred securities (see Note 12). Pursuant to FIN 46, it could be determined that (i) the Trusts are variable interest entities and (ii) the Company is not the primary beneficiary of these Trusts. If such determinations are made, the Company will be required to de-consolidate Hercules Trust I and Hercules Trust II, effective July 1, 2003.
In April 2003, the FASB issued Statement of Financial Accounting Standards No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities" ("SFAS 149"). SFAS 149 incorporates provisions that were clarified by the Derivatives Implementation Group. The provisions of SFAS 149 should be applied prospectively to contracts entered into after June 30, 2003. The Company does not believe this statement will have a material effect on its financial statements.
In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity" ("SFAS 150"). SFAS 150 requires certain financial instruments with both debt and equity characteristics to be classified as debt. The statement requires initial and subsequent valuation of this debt at a present or fair market value and is effective July 1, 2003. Upon adoption of SFAS 150 on July 1, 2003, $625 million of Company-obligated Preferred Securities of Subsidiary Trusts will be reclassified from the mezzanine section of the Consolidated Balance Sheet to the long-term liabilities section of the Consolidated Balance Sheet.
Forward-looking Statements
This quarterly report on Form 10-Q includes forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, reflecting management's current analysis and expectations, based on what management believes to be reasonable assumptions. Forward-looking statements may involve known and unknown risks, uncertainties and other factors, which may cause the actual results to differ materially from those projected, stated or implied, depending on such factors as: ability to generate cash, ability to raise capital, ability to refinance, the result of the pursuit of strategic alternatives, ability to execute Work Process Redesign and reduce costs, business climate, business performance, economic and competitive uncertainties, higher manufacturing costs, reduced level of customer orders, changes in strategies, risks in developing new products and technologies, environmental and safety regulations and clean-up costs, foreign exchange rates, the impact of changes in the value of pension fund assets and liabilities, changes in generally accepted accounting principles, legislative changes, adverse legal and regulatory developments, including increases in the number or financial exposures of claims, lawsuits, settlements or judgments, or the inability to eliminate or reduce such financial exposures by collecting indemnity payments from insurers, the impact of increased accruals and reserves for such exposures, and adverse changes in economic and political climates around the world, including terrorist activities and international hostilities. Accordingly, there can be no assurance that the Company will meet future results, performance or achievements expressed or implied by such forward-looking statements. As appropriate, additional factors are contained in other reports filed by the Company with the Securities and Exchange Commission. This paragraph is included to provide safe harbor for forward-looking statements, which are not generally required to be publicly revised as circumstances chang e, and which the Company does not intend to update.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
For discussion of quantitative and qualitative disclosure about market risk, see "Risk Factors" under Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations.
Item 4. Controls and Procedures
The Company carried out an evaluation, under the supervision and with the participation of the Company's management, including the Company's Chief Executive Officer and Vice President and Controller, of the effectiveness of the design and operation of the Company's disclosure controls and procedures pursuant to Exchange Act Rule 13a-15 as of June 30, 2003. Based upon that evaluation, the Company's Chief Executive Officer and Vice President and Controller concluded that the Company's disclosure controls and procedures are effective. Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in Company reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.
There have been no significant changes in the Company's internal controls or in other factors that could significantly affect internal controls subsequent to the date the Company carried out this evaluation.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
For information related to Legal Proceedings, see Notes to Financial Statements.
Item 4. Submission of Matters to a Vote of Security Holders
As a result of the Hercules Shareholders' Committee for New Management 's action on July 25, 2003 withdrawing their nominations to the Company's Board of Directors, the Company announced, on the same day, that Patrick Duff, Thomas P. Gerrity and John K. Wulff were elected and that Joe B. Wyatt was re-elected to the Board of Directors by the shareholders at the annual meeting. Also at the annual meeting, the shareholders voted on the ratification of PricewaterhouseCoopers LLP as the Company's independent public accountants for 2003, approval of the Hercules Incorporated Omnibus Equity Compensation Plan for Non-Employee Directors, a shareholder proposal to redeem the Rights issued pursuant to the Company's Rights Agreement dated as of August 4, 2000 and a shareholder proposal to amend the Company's Restated Certificate of Incorporation to provide for the right of shareholders to take action by written consent and to call special meetings. Final results of the voting will not be available until the indep endent inspectors of election have completed their review of the voting.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
Please see the exhibits listed on the Exhibit Index.
(b) Reports on Form 8-K
Date of Report |
Item No. |
Financial Statements Included |
May 1, 2003 |
12 |
Yes |
June 3, 2003 |
5, 7 |
No |
July 10, 2003 |
7, 9 |
Yes |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
HERCULES INCORPORATED |
|
|
By: |
/s/ Stuart C. Shears |
|
Stuart C. Shears |
|
Vice President and Treasurer |
|
(Principal Financial Officer and duly |
|
authorized signatory) |
|
August 7, 2003 |
|
|
By: |
/s/ Fred G. Aanonsen |
|
Fred G. Aanonsen |
|
Vice President and Controller |
|
(Principal Accounting Officer and duly |
|
Authorized signatory) |
|
August 7, 2003 |
EXHIBIT INDEX
Number |
Description |
Incorporated by Reference To |
3.1* |
By-Laws of Hercules Incorporated, as revised and amended as of July 15, 2003 |
|
4.1 |
Amendment No. 1 to the Hercules Incorporated Rights Agreement, dated as of June 5, 2003 |
Exhibit 4.2, Registration Statement on Form 8-A, filed June 5, 2003 |
31.1* |
Certification of Chairman and Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
31.2* |
Certification of Vice President and Controller Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
32.1* |
Certification of Chairman and Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
32.2* |
Certification of Vice President and Controller Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
* Filed herewith